Enantioselective multicomponent organoboron reactions of ortho-quinone methide intermediates catalyzed by chiral biphenols by Barbato, Keith Steven
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2016
Enantioselective multicomponent
organoboron reactions of
ortho-quinone methide
intermediates catalyzed by chiral
biphenols
https://hdl.handle.net/2144/17059
Boston University
BOSTON UNIVERSITY 
 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
Dissertation 
 
 
 
 
 
ENANTIOSELECTIVE MULTICOMPONENT ORGANOBORON REACTIONS 
OF ORTHO-QUINONE METHIDE INTERMEDIATES CATALYZED BY 
CHIRAL BIPHENOLS 
 
 
 
 
by 
 
 
 
 
KEITH STEVEN BARBATO 
 
M.A., Boston University, 2012 
B.S., University of Massachusetts Amherst, 2010 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Doctor of Philosophy 
 
2016  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
 KEITH STEVEN BARBATO 
 2016  
Approved by 
 
 
 
 
 
First Reader _________________________________________________________ 
 Scott E. Schaus, Ph.D. 
 Associate Professor of Chemistry 
 
 
 
 
 
Second Reader _________________________________________________________ 
 James S. Panek, Ph.D. 
 Professor of Chemistry 
 
 
	  	   iv 
ENANTIOSELECTIVE MULTICOMPONENT ORGANOBORON REACTIONS 
OF ORTHO-QUINONE METHIDE INTERMEDIATES CATALYZED BY 
CHIRAL BIPHENOLS 
 
KEITH STEVEN BARBATO 
Boston University Graduate School of Arts and Sciences, 2016 
Major Professor: Scott E. Schaus, Associate Professor of Chemistry 
 
 
Abstract 
 
Ortho-quinone methides are reactive intermediates with wide ranging applications 
in organic synthesis. However, their propensity to rearomatize renders them transitory 
and reactive, which has made their implementation in organic synthesis challenging. An 
asymmetric and organocatalytic multicomponent reaction platform was developed to 
address this challenge by accessing ortho-quinone methide intermediates in situ through a 
Friedel-Crafts hydroxy-alkylation condensation of phenols, aldehydes, and boronates. 
This approach provided a practical and general method to access to chiral di- and triaryl 
methane products in high yields and enantioselectivities from commercially available 
starting materials. An unanticipated cyclization pathway was discovered while exploring 
the scope of the reaction that afforded 2,4-diarylchroman products from an electron rich 
styrenyl boronate. Reaction conditions were optimized to select for the cyclization 
	  	   v 
pathway, which afforded chroman products with high levels of enantio- and 
diastereoselectivity. 
 The myristinin natural products are DNA polymerase-β inhibitors and DNA-
damaging agents that contain a privileged chroman scaffold within their core. The 
multicomponent cyclization strategy was applied towards the synthesis of the myristinin 
natural products without success. To circumvent issues with reactivity, the 
multicomponent reaction platform was extended to an intermolecular cycloaddition of in 
situ generated ortho-quinone methides from phenols, aldehydes, and styrenes to provide 
2,4-diarylchromans. The core of myristinins B/C was synthesized using the 
multicomponent cycloaddition strategy providing high yield and diastereoselectivity with 
remarkable step economy. An enantioselective version of the multicomponent 
cycloaddition reaction was developed utilizing triisopropyl borate Lewis acid and a chiral 
biphenol. 
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CHAPTER 1 
 
 
 
 
A Review of Enantioselective Organoboron Multicomponent 
Reactions in Organocatalysis 
 
 
 
 
Catalytic Organoboron Exchange Methodology 
 
The development of organoboron reagents for use in organic synthesis was 
sparked by the discovery of the hydroboration reaction.1 Boronic acids and esters in 
particular have been used extensively as nucleophiles. Boronic acid 1.1 contains a 
trivalent boron center with two hydroxyls and a carbon substituent (Figure 1.1, Eq. 1). 
The boron center is sp2-hybridized and possesses an empty p-orbital orthogonal to its 
substituents, which acts as a mild Lewis acid. Electron donation (nO → pB) into this empty 
p-orbital makes boron-oxygen bonds stronger than carbon-oxygen bonds (519 kJ/mol vs 
384 kJ/mol respectively).2 Boronic acids are activated to boron “ate” intermediates 1.2 
through the donation of electron density into its empty p-orbital from a Lewis base 
	  2	  
electron pair. In this mode of activation, the boron center becomes sp3-hybridized and 
possesses a formal negative charge, which renders the carbon substituent nucleophilic. 
The change in hybridization coincides with an increase in the boron-oxygen bond length 
by as much as 0.10 Å to form a tetrahedral geometry. 
 
 
Figure 1.1 Reactivity of organoboron reagents. 
 
The unique reactivity profile of boronic acids and esters has afforded powerful 
carbon-carbon bond forming reactions in asymmetric catalysis. For example, Roush 
demonstrated the allylation of aldehydes through a six-membered Zimmerman-Traxler 
cyclic transition state that afforded homoallylic alcohols with good stereocontrol (Figure 
1.2, Eq. 2).3 The aldehyde oxygen donates electron density into the empty p-orbital of the 
organoboron reagent to initiate the reaction; this sequence forms the nucleophilic boron 
“ate” complex and simultaneously lowers the LUMO of the aldehyde. Complex 1.6 is 
Boronate ester
B
OR
R1
OR
R1
OR
OR
sp2 hybridized,
vacant p-orbital
OR
OR
OR
sp3 hybridized,
formal negative charge
OR
OR
OR
B
R1 OR
Boron "ate" species
1.1 1.2
(1)
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proposed, which orients the lone electron pair of the coordinated aldehyde oxygen into an 
axial position that acts to reduce electron repulsion in the transition state. 
 
 
Figure 1.2 Enantioselective organoboron allylation using chiral reagent. 
 
In 1997, Petasis described a new organoboron method to access α-amino acids in 
a convenient multicomponent reaction.4 Anti-β-amino alcohols were later synthesized 
using the same strategy.5 The Petasis reaction features a three-component reaction of aryl 
or styrenyl boronic acid 1.8, an α-hydroxy aldehyde 1.9, and an amine 1.10 (Figure 1.3, 
Eq. 3). An iminium intermediate is formed in situ by the condensation of aldehyde and 
amine. The hydroxyl substituent coordinates to the empty p-orbital of boron and 
promotes ligand transfer through a tight cyclic transition state 1.12 to deliver the anti-β-
amino alcohol product 1.11 with high enantio- and diastereoselectivity (Figure 1.3a).  
B
+
OH
R
CH2Cl2 or PhCH3 
-78 °C, 24 h
up to 95% yield
71-87% ee
O
O
CO2iPr
CO2iPr
O
HR
1.3 1.4 1.5
BO
H
R
O
O
CO2iPr
OiPrO
Favored
O
B
O
O
CO2iPr
H
R
O
OiPr
Disfavored electron repulsion
1.6 1.7
(2)
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Figure 1.3 A stereoselective organoboron Petasis reaction using chiral reagent. 
 
 Asymmetric organocatalysis has recently emerged as a powerful tool to access 
enantio- and diastereoenriched products. Catalysts in these systems are typically 
inexpensive, environmentally friendly, and easily synthesized or functionalized for 
adaptability in different systems.6–9 Previous asymmetric organoboron reactions have 
relied upon stoichiometric quantities of chiral reagent or chiral auxiliary to provide 
enantioenriched products. McCusker and coworkers discovered that the intermolecular 
exchange rate of boronate ester alkoxy groups is rapid at room temperature using 1H 
NMR studies.10 Schaus postulated that the rapid exchange of ligands provided an 
opportunity for asymmetric organocatalysis if boron reagents are used in combination 
with sub-stoichiometric quantities of chiral-diol catalyst.  
R2
O
HR1
+
1.91.8
B
OH
OH OH
EtOH, 25 °C
12-48 hN
H
R4R3
1.10
R2
N
R1
OH
R4R3
+
1.11
39-88% yields
>99% ee
99% dr
(a) Model for enantioselectivity
(3)
N
R2
O
H
R4R3
H
B
R1HO
HO
1.12
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 In 2006, Schaus reported an enantioselective organocatalytic allylboration of 
ketones catalyzed by chiral diols, which provided access to homoallylic alcohols.11 A 
screening of structurally diverse chiral diols revealed 3,3’-(S)-Br2-BINOL 1.15 as a 
competent catalyst in the reaction, affording products 1.16 with high yields and 
enantioselectivities (Figure 1.4, Eq. 4). Moreover, (E)- and (Z)-crotyl boronates provided 
products 1.18a and 1.18b with good yields and impressive stereocontrol (Figure 1.4, Eq. 
5 and 6). The stereochemical outcomes of the crotylations are consistent with a 
Zimmerman-Traxler transition state model. 
 
 
Figure 1.4 An asymmetric allylboration of aryl ketones catalyzed by chiral diols. 
Ar
O
R1
OH
Br
OH
Br
+ Ar
1.13 1.14a 1.16
15 mol % (S)-1.15
3:1 PhCH3 : PhCF 
-35 °C, 15 hB
76-93% yield
95:5 - 99.5:0.5 er
OiPr
OiPr
3,3'-Br2-BINOL
(S)-1.15
OHR1
Ph
O
CH3 + Ph
1.13a 1.17a 1.18a
15 mol % (S)-1.15
3:1 PhCH3 : PhCF 
-35 °C, 15 hB
OiPr
OiPr
OHH3C
CH3
CH3
75% yield
99:1 dr
98.5:1.5 er
Ph
O
CH3 + Ph
1.13a 1.17b 1.18b
15 mol % (S)-1.15
3:1 PhCH3 : PhCF 
-35 °C, 15 hB
OiPr
OiPr
OHH3C
CH3
72% yield
98:2 dr
99:1 er
H3C
(4)
(5)
(6)
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 Mechanistic experiments were conducted to ascertain the role of the catalyst in 
the reaction. 1H NMR was used to monitor a solution of 1.14a and (S)- 1.15 over varying 
time points. An erosion of C2-symmetry in BINOL (S)- 1.15 was observed that indicated 
a catalyst-boronate complex. Moreover, the single exchange of one allylboronate 
isopropoxy ligand with (S)- 1.15 was also observed and supported the observations made 
by McCusker.  
Brown reported that electron-withdrawing alkoxy-ligands enhance the reactivity 
of allylboronates by increasing its Lewis acidity.12 Hall later described that additional 
Lewis acid coordination to boron alkoxy ligands further enhances this effect.13 Based on 
these findings, Schaus proposed a transition state model that illustrates the observed 
stereochemical outcome. The electron-deficient chiral diol catalyst increases the Lewis 
acidity of boron complex 1.19 and enhances its reactivity (Figure 1.5). The non-
coordinated phenol of catalyst (S)- 1.15 participates in a hydrogen bonding event with the 
allylboronate isopropoxy ligand to further enhance the reactivity.  
 
 
Br
O
O
Br
B
O
OH
1.19
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Figure 1.5 Proposed allylboration transition state. 
 
 Chong demonstrated an asymmetric alkynylboration of enones using 3,3’-(S)-I2-
BINOL (S)- 1.22 as a chiral diol catalyst (Figure 1.4, Eq. 7).14 This additional example 
served as a proof of principle that the organoboron exchange paradigm can work across 
multiple reaction platforms. 
 
 
Figure 1.6 Asymmetric alkynylboration of enones catalyzed by a chiral diol. 
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R3
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Addition
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O
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R3
1.25
B
OiPr
OiPr
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B
OiPr
OiPr
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 Chong proposed a mechanistic cycle of the reaction starting with the rapid 
transesterification of diol catalyst (S)- 1.22 with diisopropoxyboronate 1.21 (Figure 1.6, 
Eq. 8). Delivery of the alkyne nucleophile in the addition step is ligand-accelerated and 
sets the stereochemistry of product 1.24. Disproportionation of complex 1.24 extrudes 
product 1.25 and helps to regenerate the active catalyst. A corresponding stoichiometric 
reaction was reported for alkynylboronate 1.23 that provided similar 
enantioselectivities.15 In accordance with that report, Chong considered cyclic boronate 
complex 1.23 to be the active catalyst in this system. 
 In 2006, Goodman and Pellegrinet performed theoretical studies on this catalytic 
system using DFT calculations.16 Their results indicated that the rate enhancement of the 
ligand-accelerated process was due to the increased Lewis acidity of the diol-
organoboron complex, supporting the conclusions of Hall and Brown that electron-
withdrawing substituents serve to enhance the Lewis acidity and increase reactivity. 
Additionally, they found that delocalization of oxygen lone pair electrons into the 
aromatic system of the diol pulls electron density away from the boron p-orbital and 
produces a similar effect. 
 In a follow up study by Goodman and Pellegrinet, DFT calculations were done to 
address the chiral diol-organoboron exchange mechanism in the alkenylation of enones.17 
A model system implementing alkenyl boronate 1.27 and 3,3’-I2-biphenol (R)- 1.28 
examined the ground state energies of transesterified products (Figure 1.7, Eq. 9). In 
these conditions, single exchange product 1.29 was found to be 5.75 kcal/mol higher in 
energy than that of free boronate 1.27. The second exchange to form the cyclic boronate 
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was found to be only 0.24 kcal/mol higher in energy. Using frontier molecular orbital 
interactions, Goodman concluded that complexes 1.29 and 1.30 are both present in the 
reaction mixture in low concentrations, but that cyclic boronate 1.30 decreases the 
HOMO-LUMO energy gap in the calculated transition state more so than complex 1.29. 
 
 
Figure 1.7 DFT calculations of biphenol transesterification with boronate. 
 
The theoretical findings from Goodman are invalid and cannot be applied to 
organocatalytic BINOL systems for a number of reasons. Previous DFT calculations done 
in the literature determined the dihedral angle of BINOL to be approximately 89.4°.18 
Moreover, x-ray crystallography of a 3,3’-disubstituted BINOL derivatives display a 
dihedral angle of approximately 80°.19 The over-simplified biphenol diol (R)- 1.28 in 
Goodman’s study does not take into consideration the preferred dihedral angle of 
BINOL, which arises from a steric interaction between its binaphthyl rings; therefore, the 
groundstate energy calculations are incorrect and cannot accurately measure the 
distribution between complexes 1.29 and 1.30 in solution. Additionally, Goodman 
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assumes that the formation of cyclic boronate 1.30 is a facile process due to the loss of 
methanol, however, the transition state activation energy from 1.29 to 1.30 was not 
calculated. Consequently, it is incorrect to assume that the formation of cyclic boronate 
1.30 is preferred over the pathway leading to product. 
A follow up report from Schaus expanded the role of the asymmetric 
organocatalytic allylboration chemistry to imines and provided experimental evidence of 
a single exchange mechanism using NMR and ESI-MS studies.20 (S)-3,3’-Ph2-BINOL 
(S)- 1.33 was used to catalyze the allylation of imines in a highly selective process, 
obtaining enantiomeric ratios of 95:5 or greater (Figure 1.8, Eq. 10). 
Crotyldiisopropoxyboronates afforded highly selective addition products as well, with 
diastereomeric ratios greater than 98:2.  
 
 
Figure 1.8 An asymmetric allylation of imines catalyzed by chiral diols. 
 
 Mechanistic studies were carried out using 1H NMR, 11B NMR, and ESI-MS to 
monitor the reactions in real time. A 1:1 mixture of allylboronate 1.14a and catalyst 
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1.35a was prepared in deuterated toluene and monitored by 1H NMR for 10 hours (Figure 
1.9, Eq. 11).  
 
 
Figure 1.9 Experimental studies of mechanism. (Source: J. Am. Chem. Soc. 2007, 129, 
p. 15402).21 
 
Proton Ha in starting material 1.35a appears as a singlet due to the C2-symmetry 
of BINOL (Figure 1.9, Eq. 11). After 10 hours at room temperature in deuterated toluene, 
the transesterification of 1.35a with allylboronate 1.14a was observed through the 
desymmetrization of the diol protons Hb and Hc in complex 1.35b (Figure 1.9a). ESI-MS 
is a relatively mild process that allows access to the qualitative analysis of in situ 
generated intermediates. The mixture of 1.35a and boronate 1.14a was equilibrated for 4 
hours and then measured (Figure 1.9b). A mass corresponding to the single exchange of 
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catalyst 1.35a with allylboronate 1.14a provided further evidence of this formation. 
Moreover, Schaus and coworkers found no evidence for the formation of cyclic boronate 
in these studies. 
 The spectrometric studies of the organocatalytic exchange process provided 
important insights into the mechanism of the reaction; a deeper understanding of the 
fundamental reactivity in this exchange process allowed us to address synthetically 
challenging transformations in asymmetric organocatalysis, while also broadening the 
utility of the method. For instance, aryl-, alkenyl-, and alkynylboronate nucleophiles were 
effectively added to acyl imines under very similar conditions to afford highly 
enantioenriched products (Figure 1.10, Eq. 12-14).22 This report demonstrates the 
versatility of the organocatalytic boronate exchange process and its potential as a general 
nucleophile in organic synthesis. 
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Figure 1.10 Organoboron additions to acyl imines. 
 
The conformation of cyclic boronates acts to align the electron lone pairs of 
oxygen with the empty p-orbital of boron whereas acyclic boronates have free rotation 
about their alkoxy-ligands. Since electron donation (nO → pB) is directly proportional to 
the stability of the organoboron reagent and inversely proportional to its Lewis acidity, 
the allylation reaction rate for dioxaborinane 1.44a was a full order of magnitude lower 
when compared to acyclic boronate 1.44b or acyclic boronic acid 1.44c (Figure 1.11, Eq. 
15).12 Based on these manifestations, the scope of the boron exchange methodology was 
expanded to nucleophiles that were otherwise inaccessible with acyclic boronates.23  
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Figure 1.11 Rate of reaction in cyclic and acyclic allylborations of benzaldehyde. 
 
The addition of allenyl and propargyl boronates to aldehydes and ketones 
afforded propargylic alcohols and allenyl alcohols with impressive yields and 
enantioselectivities utilizing cyclic boronates (Figure 1.12, Eq. 16 and 17). Few methods 
exist to prepare homopropargyl alcohols 1.49 in enantioenriched form, although they 
have been routinely observed as intermediates in natural product synthesis.24 Allenols 
1.52 are valuable synthetic intermediates for the synthesis of small, complex molecules. 
Stereospecific transformations from allenols include products such as dihydrofurans, 
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cyclopropanes, vinyl epoxides, syn-1,2-diols, and syn-1,2-amino alcohols. The success of 
these transformations leveraged the stability of cyclic boronates, which are also easy to 
prepare and handle. 
 
 
Figure 1.12 Boronate scope extended using cyclic boronates.  
 
Novel modes of reactivity have been discovered using the organoboron exchange 
methodology.25 Chiral diol tartaric acid (+)-1.55 catalyzed an enantioselective [4+2] 
cycloaddition of isochromene acetals 1.53 and styrenyl boronates 1.54 in good yields and 
high enantioselectivities (Figure 1.13, Eq. 18). Tartaric acid is an ideal chiral catalyst 
since it is abundant, inexpensive, and environmentally friendly. Chiral boron ate complex 
1.57 was proposed as a key intermediate in the reaction to explain the reactivity observed. 
The 1,2-addition product 1.58 was not observed during the reaction. This development 
provided 1,2-dihydronaphthalenes structures bearing two chiral stereocenters, and more 
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importantly, opened the possibility of developing similar transformations using this 
organoboron exchange method. 
 
 
Figure 1.13 Enantioselective hetero-Diels-Alder reaction using boronate exchange 
methodology. 
 
 The boronate exchange methodology has provided a unique and general platform 
in enantioselective organocatalysis. The role of the boronate reaction partner expanded 
from allylation chemistry to a diverse variety of nucleophilic additions and even an 
enantioselective inverse electron demand cycloaddition. Previous organoboron additions 
utilized aldehydes, ketones, or imine electrophiles directly in the reaction mixture or in 
situ from precursor starting materials. To further expand the utility of this paradigm, we 
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looked at the electrophilic reaction partner as an opportunity to develop enantioenriched, 
synthetically useful intermediates that are otherwise difficult to access.  
 
Ortho-Quinone Methides in the Boronate Exchange Methodology 
 
 Ortho-quinone methides are important synthetic intermediates commonly 
encountered in chemical and biological processes.26 They contain a cyclohexadiene core 
functionalized with an exo-methylene positioned ortho to a carbonyl group 1.59 (Figure 
1.14, Eq. 19). Experimental observations have shown that ortho-quinone methides may 
undergo [4+2] hetero-Diels Alder cycloaddition reactions under amenable conditions. 
Theoretical studies using FMO have corroborated these results, but analyses must 
consider the energy gained when aromaticity is restored. It is this propensity to re-
aromatize that makes this intermediate highly reactive; a zwitterionic resonance structure 
1.60 places electron density on oxygen and removes it from the methylene carbon. 
Consequently, this renders the methide carbon highly electrophilic, which can undergo 
facile additions with nucleophiles. Additionally, the zwitterionic resonance structure 
allows for free rotation about the benzylic carbon and olefin geometry is non-static. The 
preference for Z- or E-olefin geometry in 1.60 is dictated by the energy difference 
between the competing steric interactions of R2 with R1 and C-O.27 
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Figure 1.14 Zwitterionic resonance structure of ortho-quinone methides. 
 
Ortho-quinone methides are more often than not non-isolable due to their high 
reactivity. Experimental observations indicated that substituents on ortho-quinone 
methides modulate its generation and stability. Jurd found that electron donation and 
linear conjugation have a stabilizing effect, which he used to synthesize a bench stable 
ortho-quinone methide.28 Rokita followed up with investigations and confirmed that 
electron-donating substituents are stabilizing while electron-withdrawing ones are 
destabilizing.29 An experiment was carried out to investigate these substituent effects 
using starting material 1.61, which readily forms ortho-quinone methide 1.62 upon 
exposure to a fluoride source (Figure 1.15, Eq. 20). Under identical conditions, electron-
withdrawing 1.64a, electron-neutral 1.64b, and electron-donating 1.64c products were 
formed from a reversible addition of nucleophile 1.63. Substituents were found to 
influence both the formation ortho-quinone methides and their subsequent reactivity with 
nucleophiles (Figure1.15a). An electron donating group, methyl, facilitated the initial 
formation of ortho-quinone methide 1.62c and its subsequent regeneration from product 
1.64c. The concentration of product decreased to zero over time, due to self-destructive 
pathways, such as homodimerization and oligomerization. An electron-withdrawing 
O
R2
1.59
O
R2
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substituent, ethyl ester, suppressed the initial generation of ortho-quinone methide 1.62a 
and its regeneration from the product 1.64a. A high concentration of product was still 
observed at 70 hours since this stabilization prevented equilibrium with non-desired 
pathways. 
 
 
Figure 1.15 Ortho-quinone methide substituent effects (Source: J. Am. Chem. Soc. 
2006, 128, p. 11942, Figure 1).  
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In 2002, enantioselective transformations involving ortho-quinone methides were 
sparing in the literature.27 Schaus and Luan envisioned utilizing ortho-quinone methide 
intermediates in their boronate exchange chemistry to provide synthetically useful 
products that are otherwise difficult to access. Studies were initiated to evaluate the 
reaction of boronates with a stabilized ortho-quinone methide adapted from Jurd and 
Trauner.30 A variety of conditions and chiral diols were screened in the reaction to assess 
their impact on yield and stereoselectivity, which revealed (R)-3,3’-Br2BINOL as the 
optimal catalyst.  
The scope of the reaction was explored, first looking at the stabilized ortho-
quinone methide substrates 1.65 (Figure 1.16, Eq. 21). Enantioselectivities were 
generally exceptional and substitution on the aryl substituent R2 had no noticable effect, 
though, the yield was slightly higher for the electron-withdrawing bromine substrate 
1.67c. An isolable ortho-quinone methide functionalized with a prenyl group was 
successfully prepared and gave product 1.67d with remarkable selectivity and good yield. 
Electron-rich boronates also furnished products 1.67e and 1.67f with similar results. An 
electron-rich aromatic group not containing linear conjugation was also prepared and 
reacted with styrenyl boronate that afforded product (S)-1.67a in only 1 hour.  
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Figure 1.16 Enantioselective additions to stabilized ortho-quinone methides using 
the boron exchange methodology.  
 
The low number of isolable ortho-quinone methide products truncated the scope 
of the reaction. Accordingly, methods were sought to generate ortho-quinone methides in 
situ from stable precursor starting materials under mild and controllable conditions. 
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quinone methides in situ under a number of conditions. Boronate was postulated to be 
acidic enough to promote the facile formation of an ortho-quinone methide.  
 
Table 1.1 Optimization of an organoboron alkenylation to in situ generated ortho-
quinone methides. 
 
 
 Indeed, hydroxybenzyl alcohol 1.68a was found to form ortho-quinone methide in 
situ under mild conditions (Table 1.1). (R)-3,3’-Br2BINOL was selected as the optimal 
catalyst, providing product 1.70a in 53% yield and 75:25 er (Table 1.1, Entry 1). To 
facilitate the formation of the ortho-quinone methide by dehydration, 4 Å molecular 
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sieves were added to the reaction mixture, which provided a boost in yield and 
enantioselectivity (Table 1.1, Entry 2). Benzyl ether 1.68b was prepared to further 
facilitate the formation of ortho-quinone methide as a good leaving group, which 
provided excellent results (Table 1, Entry 3). Optimal conditions were found at lower 
temperatures, giving 92% yield and 97.5:2.5 er of product 1.70b. Free phenol was 
determined to be crucial for reactivity and corroborates the formation of ortho-quinone 
methide (Table 1.1, Entries 5 and 6). 
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Figure 1.17 Enantioselective additions to in situ generated ortho-quinone methides. 
 
A series of 2-hydroxybenzyl ethers were evaluated using the optimized 
conditions, which gave a variety of diaryl methane products in high yields and 
enantioselectivities (Figure 1.17, Eq. 22). Electron-donating groups affixed to the 2-
hydroxybenzyl ethers were required to provide stabilization to the in situ generated ortho-
quinone methide intermediate. Still, yields and selectivities were preserved regardless of 
substitution patterns and this allowed for additional substrates to be synthesized. Thus, 
the strategy of generating ortho-quinone methides in situ significantly increased the 
scope of the methodology.  
 
Enantioselective Organocatalytic Multicomponent Boronate Reactions 
 
 Asymmetric multicomponent reactions (MCRs) are regarded as a powerful 
reaction-type that rapidly assemble complex molecular architectures within a single 
transformation.31 MCRs are defined as three or more reagents added serially in a single 
vessel that yield enantio- or diastereoenriched product which contains a portion of each 
component. There are three types of MCRs as reported by Ugi and Domling.32 Type I 
MCRs maintain equilibrium across starting materials, intermediates, and product; thus, 
product distributions are dictated by thermodynamic control of the system. Type III 
MCRs are comprised of all irreversible steps, which are typically the case in cascade or 
domino reactions. Type II MCRs are most desirable in organic synthesis; all reaction 
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intermediates are in a dynamic equilibrium that ultimately leads to an irreversible step to 
afford product.33  
 
 
Figure 1.18 Petasis-borono Mannich is a Type II MCR. 
 
The Petasis-borono Mannich reaction is a type II MCR that has proven to be quite 
valuable in organic synthesis. In the direct pathway to product, imine or iminium 
intermediate 1.76 is formed after the condensation of aldehyde 1.74 and primary or 
secondary amine 1.75 (Figure 1.18, Eq. 23). Boronic acid 1.73 coordinates to the α-
hydroxy substituent, forming zwitterionic intermediate 1.77. Boron is activated to its ate 
complex and irreversibly transfers its ligand to form product 1.78. The organoboron 
addition is the only irreversible step in the process and intermediates in equilibrium 
ultimately funnel towards the desired product. 
This organoboron MCR developed into a highly versatile reaction platform, 
providing a diverse assortment of accessible structures.4,5,34 The reaction of aryl- or 
styrenyl boronic acids 1.73 with α-keto acids 1.74a and amines 1.75 afforded α-amino 
acids 1.78a (Figure 1.19, Eq. 24). Enantiopure α-aminoaldehydes 174.b provided β-
amino alcohols 1.78b with extremely high levels of enantio- and diastereoselectivity 
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(Figure 1.19, Eq. 25). Many aldehyde and amine derivatives have found utility in 
synthesis; for example, salicylaldehydes 1.79 are competent in the reaction and yield 
aminoalkyl phenols 1.80 (Figure 1.19, Eq. 26).  
 
 
Figure 1.19 Accessible products from the Petasis reaction.  
  
Schaus and Lou recognized the potential of this MCR in the context of their 
organoboron exchange methodology, and in 2008, developed the first asymmetric 
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chiral α-amino acids in high yields and enantioselectivities (Figure 1.20, Eq. 27). A 
similar method was developed later in a collaboration between Schaus and Schreiber to 
access syn β-amino alcohols selectively, which were otherwise inaccessible from the 
Petasis reaction.36  
 
 
Figure 1.20 Enantioselective Petasis reaction catalyzed by chiral biphenols. 
 
 Type II MCRs rely on compatible functional groups, dynamic equilibrium 
between reaction intermediates, and a single irreversible transformation. The Petasis 
reaction exemplified that boronate reagents are uniquely suited for type II MCRs, since 
they must be activated to an ate complex in order to irreversibly deliver the nucleophile.  
Moreover, boronate reactivity is easily adjusted by the choice of the alkoxy ester ligand, 
which is a significant advantage if competing irreversible pathways are present.  
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Figure 1.21 Envisioned route to ortho-quinone methide intermediates in MCR 
involving boronate. 
 
 Schaus and Lou demonstrated that the boronate exchange methodology could be 
extended to the Petasis MCR to access chiral α-amino acids in an efficient and extremely 
practical transformation. The successful implementation of the boronate exchange 
methodology in the MCR prompted us to develop a complementary method to access and 
transform ortho-quinone methide intermediates. The envisioned type II MCR proceeds 
through the condensation of phenols 1.88 and aldehydes 1.89 (Figure 1.21, Eq. 28).37–39 
Activated boron ate complex 1.90 delivers the nucleophile to furnish benzylic chiral 
carbons in an irreversible last step. This multicomponent strategy accesses ortho-quinone 
methides in situ and provides a practical method for their formation since the starting 
materials are all commercially available. Additionally, a variety of boronate nucleophiles 
could be used to access diverse libraries of natural product-like molecules in a highly 
convergent transformation. Herein, a novel MCR platform to access and transform in situ 
generated ortho-quinone methides is described. 
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CHAPTER 2 
 
 
 
 
Enantioselective Multicomponent Condensation Reactions of Phenols, 
Aldehydes, and Boronates Catalyzed by Chiral Biphenols 
 
 
 
 
Introduction 
 
 Ortho-quinone methides are useful synthetic intermediates that possess a broad 
reactivity profile.26 They typically undergo three distinct modes of reactivity: 
nucleophilic additions at the exo-methylene carbon; [4+2]-inverse electron demand 
cycloadditions with dienophiles; and, electrocyclizations if R1 is unsaturated (Figure 2.1, 
Eq. 1-3). The high reactivity of ortho-quinone methides comes from its inherent 
inclination to rearomatize, which has made its utility in synthesis challenging.27 Despite 
these difficulties, all three modes of reactivity have been exploited in organic synthesis. 
Pettus demonstrated a diastereoselective cycloaddition of ortho-quinone methides to form 
chroman acetals, which he later applied to the synthesis of (+)-R-Mimosifoliol.40 A 
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notable example from E.J. Corey used an ortho-quinone methide intermediate to install a 
thiol-bridge into Ecteinascidin 743. Trauner utilized a 6π-electrocyclization of an ortho-
quinone methide to complete a biomimetic total synthesis of Mollugin.41 
 
 
Figure 2.1 Ortho-quinone methide modes of reactivity. 
 
 The diversity of transformations involving ortho-quinone methide intermediates 
has increased as methods to control their formation and reactivity have improved. 
Consequently, enantioselective transformations of ortho-quinone methides have recently 
gained attention, but still face many challenges due to their instability and lifetimes in 
solution.42,43 Recently, we reported the enantioselective addition of boronates to stabilized 
and in situ generated ortho-quinone methides, providing access to chiral diaryl methane 
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products.44 However, all examples of enantioselective transformations are still limited to 
the construction of bench stable precursor starting materials to generate ortho-quinone 
methides in situ. A general method that employs commercially available starting 
materials to access ortho-quinone methide intermediates is absent from the literature. The 
contents of this chapter will address this deficit by introducing a boron-mediated 
enantioselective multicomponent condensation reaction involving ortho-quinone methide 
intermediates that is catalyzed by chiral biphenols. 	    
	  32	  
Background 
 
Ortho-Quinone Methide Chemistry 
 
 Ortho-quinone methides have only recently gained notoriety because their 
transient nature has made them difficult to study.45 In an early investigation into these 
reactive intermediates, Gardner and coworkers subjected a dilute concentration of ortho-
hydroxybenzyl phenol 2.5 to a reaction temperature of 500-650ºC in a quartz tube and 
then trapped the pyrolysate in liquid nitrogen.46 A trimeric molecule 2.7 was observed 
upon warming to room temperature, which they believed to have passed through an 
ortho-quinone methide intermediate 2.6 (Figure 2.2, Eq. 4). IR spectroscopy was used in 
1971 to measure the formation of ortho-quinone methide intermediates in solution.47 
Since then, NMR and X-ray crystallography of stable metal-stabilized ortho-quinone 
methides have provided direct evidence of their existence.48,49 
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Figure 2.2 Ortho-quinone methide trapping by trimerization. 
 
 Methods to generate ortho-quinone methide intermediates in situ are diverse, 
which utilize tautomerization, photolysis, acidic and basic conditions, thermolysis, and 
oxidation strategies.27 In one such example, Jurd and Wong initiated the formation of an 
ortho-quinone methide through the tautomerization of a para-quinone methide 2.8 at 
90ºC in methanol (Figure 2.3, Eq. 5).50 Ortho-quinone methide intermediate 2.9 reacted 
with itself in a homodimerization process to form the hemi-ketal product 2.10. 
Tautomerization is a mild strategy towards ortho-quinone methide formation; however, it 
requires an activated allylic proton as well as the preparation of starting material 
substrates. 
 
 
Figure 2.3 Generation of ortho-quinone methide intermediates via tautomerization. 
 
  Oxidants are a common method to promote ortho-quinone methide formation, so 
long as the target molecule does not have para-substitution containing α-protons.  This 
structural prerequisite prevents the formation of a para-quinone methide, which is less 
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polarized and typically more stable. Waters was amongst the first chemists to generate 
ortho-quinone methide intermediates in situ from oxidation using a stream of air and iron 
stearate.51 Bolon demonstrated the facile generation of ortho-quinone methide 2.12 from 
the oxidation of phenol 2.11 using silver(I) oxide, which dimerized in situ to spirocycle 
product 2.13. Silver(I) oxide was found to be the superior oxidant of choice due to its 
ease of oxidation and generality.52,53  
 
 
Figure 2.4 The generation of ortho-quinone methides via oxidation. 
 
 Chemists have also relied heavily on thermolysis to generate the ortho-quinone 
methide intermediates from stable precursors.  Unfortunately, harsh temperatures were 
typically required to generate the ortho-quinone methide intermediates, which lead to 
uncontrolled reactivity.  This included a compromise in stereoselectivity, a structural 
requirement of extended conjugation to promote ortho-quinone methide formation, and 
the condition that nucleophiles be thermally stable. Despite the restrictions, thermolysis 
has been the method of choice in synthesis. In a typical case, a precursor molecule is 
synthesized that readily forms an ortho-quinone methide when subjected to heat. In one 
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example, Lau utilized a benzodioxaborin 2.14 as a stable ortho-quinone methide 
precursor (Figure 2.5, Eq. 7).39 High temperatures were required to activate the 
benzodioxaborin species, which ranged from 230ºC to 300ºC depending on the R 
substituents and dienophile 2.16 combination. In one example, a Friedel-Crafts hydroxy-
alkylation condensation between a phenol 2.18 and aldehyde 2.19 was used to form a 
dioxaborin intermediate. However, they discovered that the high temperatures facilitated 
the direct formation of an ortho-quinone methide to furnish product 2.20 in 45% yield 
(Figure 2.4.2). Later, Lau and Dufresne found Bronsted and Lewis acids could be 
employed to lower the temperature requirements for reactions involving 
benzodioxaborins. 
 
 
Figure 2.5 Thermolysis to generate ortho-quinone methides. 
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The high reactivity of ortho-quinone methides creates a tendency for their self-
destruction in solution, which Pettus proposed as the central reason they are underutilized 
in synthesis.54 The problem arose from competing pathways between self-destruction and 
nucleophilic addition. Still, the challenge of conjugate additions to ortho-quinone 
methides has largely remained unresolved.27 
 
 
Figure 2.6 Ortho-quinone methide formation measured by UV-vis spectroscopy. 
 
High concentrations of nucleophilic trapping agent were used to outcompete the 
self-destructive pathways. In 1984, Attwood55 used UV-vis spectroscopy to monitor the 
formation of an ortho-quinone methide. He treated 5-hydroxyflavan 2.21 with acid and 
observed the appearance of a band at 395 nm, which is known to be the π-π* transition of 
an ortho-quinone methide 2.22 (Figure 2.6, Eq. 9).56 After 19 hours, benzenesulfinate 
was added, which he rationalized to participate in the conjugate addition, causing the 
band to disappear. Although the utility of this particular reactivity is limited, it provided 
an initial strategy for many new conjugate additions with wide-ranging applications.57–59 
 Lei and coworkers rationalized that the biomimetic synthesis of tocopherol trimer 
(±)-schefflone 2.27 proceeded through a spiro-chroman hetero-Diels-Alder 
homodimerization of ortho-quinone methide intermediate 2.25 (Figure 2.7, Eq. 10).60 The 
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generation of the ortho-quinone methide was realized through oxidation of espintanol 
2.24 using silver(I) oxide. A trapping experiment was done to confirm the existence of 
ortho-quinone methide intermediate in solution, whereby excess electron-rich dienophile 
ethyl vinyl ether was added to the reaction mixture generating chroman acetal 2.26 in 
nearly quantitative yield. 
 
 
Figure 2.7 Trapping experiment revealed ortho-quinone methide as reactive 
intermediate in the trimerization of espintanol. 
 
Enantioselective Additions to Ortho-Quinone Methides 
 
The development of enantioselective transformations of ortho-quinone methides 
has recently been initiated. At the forefront of this effort was Sigman, who discovered a 
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palladium(II)-catalyzed dialkoxylation of ortho-vinyl phenols. He initiated studies to 
control over the rate of β-hydride elimination in palladium catalyzed cross coupling 
reactions.61 While exploring this matter, he was surprised to find that palladium(II) in 
methanol catalyzed a isomerization/dialkoxylation sequence for 2-propenyl phenols that 
resulted in difunctionalized phenol products 2.29 (Figure 2.8, Eq. 11).  
Palladium was previously shown to form ortho-quinone methides from ortho-
vinyl phenols in the synthesis of carpanone by Chapman.62 A series of reactions were 
used to investigate the mechanism of this reaction, which revealed an in situ generated 
ortho-quinone methide intermediate 2.31 (Figure 2.8, Eq. 12). The reaction is initiated by 
the coordination of palladium(II) to the olefin 2.28.  Nucleopalladation of this complex 
with methanol affords palladium substituted compound 2.30.  Decomposition of this 
complex reduces the metal and generates the ortho-quinone methide 2.31, which is 
coordinated and stabilized by palladium(0). Nucleophilic attack with a second equivalent 
of methanol extrudes the product 2.29 with modest diastereoselectivity.  An oxidant is 
then needed to oxidize palladium(0) and regenerate the active palladium(II) complex.  
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Figure 2.8 Palladium(II) catalyzed dialkoxylation of ortho-vinyl phenols and 
proposed mechanism. 
 
Few enantioselective transformations of this reaction-type were reported in the 
literature. Consequently, Sigman and coworkers designed experiments to broaden the 
utility of the palladium mediated difunctionalization methodology. Mechanistic 
experiments were conducted and revealed that (S)-Quinox ligand 2.33 is coordinated to 
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palladium in the enantiodetermining nucleopalladation event (Figure 2.9, Eq. 13).63 
Difunctionalization provided products 2.34 in modest yields and selectivities. Sigman 
sought to increase the value of this method and envisioned functionalizing an alkene with 
two distinct nucleophiles.64 An intramolecular nucleopalladation strategy using substrate 
2.35 was developed in order to avoid a β-hydride elimination pathway, which would 
inhibit the second nucleophilic addition (Figure 2.9, Eq. 14). The consequence of this 
decision allowed for a number of different alcohol nucleophiles to be employed, giving 
chiral products 2.37 in generally good yields and selectivities. The scope of nucleophiles 
could be expanded to the use of indole derivatives 2.39, which were successfully added 
across the olefin in an electrophilic aromatic substitution (Figure 2.9, Eq. 15).65 Their 
choice of indole derivatives opened the door for other heterocycles as well.66 Products 
obtained from this reaction were screened against MCF-7 tumor cell lines, which gave 
modest selectivity over MCF-10A normal breast cells. 
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Figure 2.9 Asymmetric nucleophilic additions to ortho-quinone methide 
intermediates catalyzed by palladium(II). 
 
The degree of ortho-quinone methide reactivity is often determined by the method 
of generation. For instance, ortho-quinone methides generated under high temperatures 
often suffer from uninhibited polymerization and oligomerization pathways. Peripheral 
functionality on the ortho-quinone methide also dictates its general reactivity and 
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stability.67 In a seminal report by Jurd, he demonstrated that extending the conjugation of 
the quinone methide renders the intermediate unusually stable.28 This breakthrough 
resulted in a surge of transformations utilizing conjugated, bench-stable ortho-quinone 
methides. In one such example, Lectka provided access to chiral 3,4-dihydrocoumarin 
products from a bench stable ortho-quinone methide 2.41 developed by Jurd (Figure 
2.10, Eq. 16).68 Enantio- and diastereoenriched products are constructed through the step-
wise addition of silyl ketene acetals to bench stable ortho-quinone methides catalyzed by 
chiral ammonium fluoride catalyst 2.43.  
 
 
Figure 2.10 Asymmetric formal cycloaddition of stabilized ortho-quinone methide. 
 
N-Heterocyclic carbenes (NHC) were used by Ye to catalyze a [3+4] annulation 
of stabilized ortho-quinone methides 2.45 and enals 2.46 to give benzolactones in high 
yield and typically high er (Figure 2.11, Eq. 17).69 The authors proposed the formation of 
a Breslow intermediate from the enal and NHC catalyst 2.47 to initiate the reaction. A 
Michael addition onto the stabilized ortho-quinone methide, followed by an annulation 
via intramolecular lactonization closed the 7-membered ring 2.48 and regenerated the 
NHC catalyst. Following this work, Scheidt demonstrated similar reactivity with in situ 
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generated ortho-quinone methides and expanded the reaction partner scope to both 7-
membered lactone rings and substituted dihydrocoumarins.70,71  
 
 
Figure 2.11 Enantioselective N-heterocyclic carbene catalyzed [4+3] annulation of 
stabilized ortho-quinone methide. 
 
 Schaus and Luan demonstrated enantioselective additions of boronates to ortho-
quinone methides catalyzed by chiral biphenols.43 Stabilized ortho-quinone methides 
2.49 were prepared and reacted with boronate nucleophiles 2.50 in the presence of a 
chiral BINOL-derived catalyst (R)-2.51 to obtain chiral diaryl methane products 2.52 in 
high yields and selectivities  (Figure 2.12, Eq. 18). They articulated that the substrate 
scope was limited to isolable ortho-quinone methides and subsequently developed a 
method to generate these reactive intermediates under mild acidic conditions. Benzyl 
ether 2.53 precursor was synthesized to generate ortho-quinone methides in situ, which 
had previously been established in literature (Figure 2.12, Eq. 19).46,72–75 The in situ 
formation of ortho-quinone methide in the presence of BINOL catalyst (R)-2.51 was 
found to be a facile transformation under mild conditions, giving chiral diarylmethane 
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products 2.55 in high yields and enantioselectivities for a large variety of electron rich 
substrates. 
 
 
Figure 2.12 Enantioselective additions of boronates to bench stable and in situ 
generated ortho-quinone methides catalyzed by a chiral biphenol. 
 
 Recently, asymmetric transformations of in situ generated ortho-quinone 
methides from stable precursors have become more and more abundant in the literature.76 
At the forefront of this research was Bach in 2011, disclosing an enantioselective Friedel-
Crafts reaction of indoles utilizing this approach.77 They initiated a study utilizing chiral 
phosphoric acids derived from BINOL. It was found that biphenol 2.56 underwent a 
reaction in the presence of phosphoric acid catalyst (R)-2.58 (Figure 2.13, Eq. 20). 
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enantioselectivity was observed.  However, adjusting the solvent to trifluorotoluene and 
adding molecular sieves, enantiomeric excesses as high as 77% were obtained.  With this 
reactivity reported in the literature, a collection of accounts came out utilizing similar 
conditions.   
 
 
Figure 2.13 Enantioselective addition of indoles to ortho-quinone methide 
intermediates. 
 
Following up on the efforts of Schaus and Bach, Schneider and coworkers 
demonstrated multiple asymmetric nucleophilic additions to in situ generated ortho-
quinone methides utilizing the stable diol precursor and catalytic Bronsted acid platform. 
Their first report came in 2014, detailing the addition of β-dicarbonyls 2.61 to ortho-
quinone methides precursors (Figure 2.14, Eq. 21).78,79 This sequence employs the use of 
ortho-hydroxy benzhydryl alcohol 2.60, which undergoes elimination to extrude water 
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chromenes 2.63 were synthesized in generally excellent yields and high 
enantioselectivities after a brief exposure to toluene sulfonic acid at 40 °C. 
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Figure 2.14 Enantioselective additions to ortho-quinone methides intermediates. 
 
Schneider expanded the nucleophilic partners to indoles 2.64 and naphthols 2.66 
in order to extend the scope of this reactivity platform (Figure 2.14, Eq. 22 and 23). The 
nucleophilic addition of indoles to the in situ generated ortho-quinone methides 
drastically improved upon the method provided by Bach, giving typically high yields and 
selectivities.  Predictably, naphthols were also well tolerated, giving similar results. 
Shortly after the publication of this work, Rueping came out with an analogous method to 
prepare these structures using a highly acidic BINOL-derived N-triflyphosphoramide 
catalyst.83 
After the initial reports, Schneider and coworkers made significant improvements 
to the reaction by expanding the scope of both reaction partners. Enamides 2.68 with 
highly varied structural components followed the same mode of reactivity (Figure 2.14, 
Eq. 24). In the same regard, propargylic alcohols 2.71 were prepared to serve as ortho-
quinone methide precursors capable of the same reactivity profile, demonstrating the 
possibility of different ortho-quinone methide precursors working in this system (Figure 
2.14, Eq. 25).  In both cases, BINOL-derived phosphoric acid catalyst (R)-2.69 gave 
highly enantio- and diastereoenriched tetrahydroxanthene products 2.70 and 2.72 from 
their respective ortho-hydroxy benzylic alcohol starting materials in a stepwise addition-
cyclization.  
Within the year, Sun also demonstrated a successful example of this reaction 
platform. He implemented a chiral spirocyclic phosphoric acid diol catalyst (R)-2.75 to 
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construct quaternary stereocenters from benzylic alcohols 2.73 and indoles 2.74 (Figure 
2.15, Eq. 26).84 Mechanistic studies revealed that the indole NH provided a hydrogen-
bonding interaction that was essential for asymmetric induction. 
 
 
Figure 2.15 Enantioselective additions to ortho-quinone methide intermediates. 
 
A new organocatalytic platform of enantioselective nucleophilic additions to in 
situ generated ortho-quinone methides came out of three different laboratories 
independently in 2015.  Each group utilized a 1,6-H shift of an ortho-vinyl phenol that 
provided a reactive ortho-quinone methide in situ from catalytic quantities of phosphoric 
acid.76 Although the ortho-vinyl phenol starting material originated from Sigman’s work 
in 2006,61,85 the metal-free mode of reactivity is novel to ortho-quinone methide 
chemistry.  
Shi was the first to demonstrate the enantioselective Friedel-Crafts alkylation of 
phenylhydrazones with ortho-vinyl phenols catalyzed by a chiral phosphoric acid 
catalyst.  However, the usefulness of this method is limited to high catalyst loading, low 
yields and moderate enantioselectivity.86 Shortly afterward, Sun demonstrated this 
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concept effectively in the organocatalytic asymmetric synthesis of 1,1-diarylethanes 2.80 
(Figure 2.16, Eq. 27).87 BINOL-derived phosphoric acids were found to protonate the 
ortho-vinyl phenol 2.77 and stabilize the newly formed ortho-quinone methide 
intermediate, which a mechanistic investigation later revealed to be the rate-limiting step. 
The hydroxyl group on the starting material phenol acted as a directing group for the 
chiral catalyst in a hydrogen bonded intermediate, which they protected with TMS at the 
end of the reaction for easier purification. After formation of the ortho-quinone methide, 
the Hantzsch ester 2.78 delivered a hydride immediately in an irreversible addition to 
furnish the 1,1-diarylethane product 2.80 in good yields and high selectivities. In this 
work, Sun found that para-vinyl phenols are capable of similar reactivity and proceed 
through a para-quinone methide. Moreover, nucleophilic additions took place when the 
Hantzsch ester was exchanged with an indole. After a suitable catalyst was found, 1,1,1-
triarylalkane products 2.82 were formed in high yields and selectivities (Figure 2.16, Eq. 
28).  
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Figure 2.16 Enantioselective additions to an ortho-quinone methide intermediate 
from vinyl phenol. 
 
Shortly after this work, Wu reported an intermolecular Friedel-Crafts reaction for 
the construction of quaternary stereocenters from ortho-vinyl phenols catalyzed by the 
same chiral phosphoric acid from Sun and coworkers. The substrates and conditions used, 
as well as the results obtained, were nearly indistinguishable.88 Recently, several other 
groups have reported asymmetric additions to ortho-quinone methides generated in situ 
from the extrusion reactions of precursor starting materials. These enantioselective 
transformations provided access to enantioenriched benzyl thiols, dihydrocoumarins, and 
4H-chromenes in good yields and selectivities.70,71,89–92 
 
Multicomponent Access to Ortho-Quinone Methides 
 
A recent surge of reports exploiting the in situ generation of ortho-quinone 
methides from stable precursors has not only confirmed their synthetic utility in 
asymmetric catalysis, but has also laid the groundwork for ingenuity. The advantage of 
stable precursors is two-fold; otherwise inaccessible substrates, such as non-bench stable 
ortho-quinone methides can be accessed to furnish enantioenriched products for the first 
time.  Additionally, mild protocols can be used to facilitate and control ortho-quinone 
methide formation. Consequently, this allowed for the development of novel 
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transformations with highly enantioenriched products. Thus, the generation of ortho-
quinone methides in situ is an exceptional approach to accessing these reactive 
intermediates under carefully controlled conditions. 
It was Pettus in 2000 who pioneered the field of in situ generated ortho-quinone 
methides, showcasing a novel method to access ortho-functionalized phenols using mild, 
anionic conditions.93 The motivation for this work was to access the reactive intermediate 
in situ by the development of a cascade reaction, triggered under basic conditions. This 
approach was non-trivial though, since base facilitated both the formation of the 
precursor and the triggering of ortho-quinone methide intermediate. Fortunately, 
investigations eventually lead to a functional and controllable method. The sequence 
began with the nucleophilic addition of an organometallic reagent to an o-Boc protected 
salicylaldehyde 2.83, forming metal stabilized benzyloxy-anion 2.84 (Figure 2.17, Eq. 
29). Transfer of the Boc group furnished 2.85, a step facilitated by the newly formed 
anion, which rapidly reassembled to 2.86. The choice of organometallic reagent used 
dictated where resting intermediates lay in the cascade; aluminum reagents proceeded to 
2.84, lithium reagents proceeded further along the cascade to 2.86, and Grignard reagents 
were the most reactive, which facilitated the formation of the ortho-quinone methide 2.87 
in one pot. Later, the effectiveness of this method was demonstrated in his 
enantioselective synthesis of (+)-mimosifoliol 2.91 in 9 steps and 35% overall yield 
(Figure 2.17, Eq. 30).  
Highly diastereoselective cycloadditions with ortho-quinone methides under these 
conditions are known to occur at low temperatures.94 In this case, key intermediate 2.90 
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was accessed through the Grignard mediated cascade in the presence of chiral auxiliary (-
)-2.89 to deliver the product in 69% yield with high enantio- and diastereoselectivity.40  
 
 
Figure 2.17 Organometallic cascade reaction involving an ortho-quinone methide 
and its application to (+)-mimosifoliol. 
 
The Friedel-Crafts reaction is an efficient method to generate substituted aromatic 
structures.95 In the Friedel-Crafts hydroxy-alkylation variant between a phenol and 
OBoc
O
H
OBoc
OM
R1
R1M
O
O
R1
OM
O
O
O
R1
M
O
O
2.87
R1
O
2.83 2.84 2.85
2.86
nucleophilic 
additions
cycloadditions
reductions
(29)
(30)
CO2 (g)
-OBoc
H
O
OBocTMS(H2C)2O
H3CO
2.88
Ph
OTMS(H2C)2O
H3CO
O Ph
H
PhMgBr Et2O
-78 °C→rt
Ph
H
O
H
(-)-2.89
+
69% yield
95% ee
>20:1 dr
2.90
2.90
Ph
OCH3HO
H3CO
(+)-mimosifoliol
2.91
9 steps total
35% overall yield
	  53	  
aldehyde, the condensation reaction proceeds under Lewis acidic conditions.96 This 
process was used extensively to create stable ortho-quinone methide precursors across 
multiple reaction platforms. However, Friedel-Crafts initiated multicomponent 
transformations involving ortho-quinone methides have only recently been realized. 
 In 2005, Moghanian discovered a simple and convenient method for the synthesis 
of dibenzoxanthenes via the condensation of an aldehyde with two equivalents of β-
naphthol.97 The scope of this in situ generated ortho-quinone methide condensation was 
investigated to expand its reactivity towards a multicomponent platform with 
differentiated nucleophiles.98 After screening catalyst, solvent, and nucleophile 
combinations, Moghanian and coworkers were pleased to find conditions suitable for 
such a transformation to occur. Under acidic conditions, using toluenesulfonic acid in 
1,2-dichloroethane, the three-component condensation between β-naphthol 2.92, 
aldehydes 2.93, and urea derivatives 2.94 provided access to racemic amidoalkyl 
naphthols 2.95 in generally high yields, regardless of the electronics across the aldehyde 
(Figure 2.18, Eq. 31). Mechanistic studies indicated an ortho-quinone methide was the 
likely pathway leading to product, though, a Mannich-type mechanism could not be not 
ruled out.99,100  
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Figure 2.18 Multicomponent reaction of ortho-quinone methide intermediate. 
 
In the context of ortho-quinone methide chemistry, direct entry to the reactive and 
often transient intermediate starting from commercially available, bench stable starting 
materials is an attractive prospect. Multicomponent reactions are notable for their ability 
to access complex architectures in a single transformation; likewise, this convergent 
approach allows for the rapid diversification of products. Unsurprisingly, multiple 
reactions of this type were published within the next few years, providing access to 
related scaffolds.101–107 
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Figure 2.19 Multicomponent reaction of ortho-quinone methide to access 
robustadials A and B. 
 
In one elegant example, Singh demonstrated the practical utility of this reaction 
by way of his two step synthesis of robustadials A and B 2.99 with an overall yield of 
27% (Figure 2.19, Eq. 32).108,109 Dialdehyde 2.96 was prepared by the diformylation of 
phloroglucinol, while isovaleraldehyde 2.97 and (-)-β-pinene 2.98 were already 
commercially available. Treatment of the starting materials with sodium acetate and 
acetic acid under microwave irradiation resulted in a 68% yield of robustadials A and B.  
Due to the sterics of the styrene moiety, the cycloaddition occurs from the non-hindered 
face, giving a mixture of only two diastereomers. Singh and coworkers later mimicked 
this multicomponent method in the synthesis of euglobal natural products.108 
Although this multicomponent condensation approach has been used to synthesize 
natural products and interesting scaffolds, there are currently no examples of an 
organocatalytic, asymmetric, multicomponent reaction proceeding through an ortho-
quinone methide. The enantioselective addition of boronates to ortho-quinone methides 
reported by Schaus in 2012 provided enantioenriched diarylmethane products from 
stabilized ortho-quinone methides; likewise, hydroxybenzyl ethers as ortho-quinone 
methide precursor molecules were constructed to expand the scope of the reaction.43 To 
improve upon this method, we envisioned extending the scope of this enantioselective 
reaction to a multicomponent condensation, forming ortho-quinone methide 
intermediates in situ from commercially available starting materials.  
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It is known that boron is capable of mediating Friedel-Crafts hydroxy-alkylation 
reactions.37,38,57,110–113 In 1960, Peer provided evidence that boric acid is capable of 
mediating a Friedel-Crafts hydroxy-alkylation process between phenol 2.100 and 
formaldehyde 2.101 in benzene at 80 °C (Figure 2.20, Eq. 33). Hydrolysis of the product 
furnishes the benzyl alcohol 2.103 and regenerates boric acid. The reaction does not 
proceed in the absence of boric acid and provides only substitution ortho to the phenol; 
these observations imply that boron is responsible for facilitating the regioselective 
addition. 
 
 
Figure 2.20 Boron mediated Friedel-Crafts hydroxy-alkylation reaction. 
 
 Dufresne and Lau followed up on the work of Peer, reporting the ortho-specific 
alkylation of phenols to form 1,3,2-benzodioxaborins 2.106, which is now known to be a 
stable ortho-quinone methide precursor (Figure 2.21, Eq. 34). Benzodioxaborin is 
procured in one step from phenyl boronic acid, propionic acid, and refluxing toluene, a 
procedure derived from Nagata.38 Over the course of several years, Lau and Dufresne 
reported a diverse collection of products obtained from this important precursor.39,110,111 
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For instance, aluminum trichloride and alcohol furnishes ortho-disubstituted phenols 
2.108, while dienophiles in acidic conditions construct chromans 2.110 from an 
intermolecular cycloaddition.  
  
 
Figure 2.20 Benzodioxaborin precursor to ortho-quinone methide intermediates. 
 
The wide-ranging synthetic applications of ortho-quinone methides prompted us 
to develop a multicomponent platform for directly accessing these reactive intermediates 
in situ from commercially available starting materials. Currently, asymmetric 
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transformations of in situ generated ortho-quinone methides are limited by the 
construction of a stable precursor. Herein, we report an enantioselective multicomponent 
condensation reaction to form ortho-quinone methides through a bimolecular process 
involving a phenol and aldehyde, mediated by boronate and catalyzed by a chiral 
biphenol.  	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Results and Discussion 
 
Optimization of the Multicomponent Reaction 
 
At the outset of this investigation, the initial reaction conditions selected were 
formulated from the known organoboron mediated Friedel-Crafts hydroxy-alkylation 
reaction,39 as well as the conditions engineered by our group in a previous report.43 We 
envisioned a multicomponent reaction sequence between an electron-rich phenol, an 
aldehyde, and a styrenyl boronate. A small collection of diverse chiral diol scaffolds was 
assessed in the multicomponent reaction, each of which are known to promote 
enantioselective transformations in previous organocatalytic methodologies (Table 
2.1).114–116 After 48 hours of stirring at 80 °C in toluene, (R)-BINOL was found to give 
96% yield with low enantioselectivity (Table 2.1, Entry 3).  Functionalizing the 3,3’-
positions of BINOL has been shown to improve enantioselectivity by creating a steric 
environment in the enantio-determining step. In agreement with our previous studies of 
ortho-quinone methides, (R)-3,3’-Br2-BINOL 2.121 was identified as producing the 
highest levels of yield and stereoselectivity, which was carried forward for additional 
optimizations.43 
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Table 2.1 Multicomponent reaction optimizations.
 
 
O
O OH
O
+
2.111a 2.112a
O
O OH
H B
RO
RO
2.114a
OH
OH
HO
O
OH
OOH
OH
Ph
Ph
OH
OH
X
X
2.118: X = H
2.119: X = F
2.120: X = b-naphthyl
2.121: X = Br
2.116
2.117
2.113a
catalyst 80 °C 
PhCH3 24 h
1
2
3c
4
5
6
7
8
9d
12g
10e
11f
13
14
entry catalyst catalyst loading
(mol %)
concentration 
[M]
R yield [%]a erb
2.116
2.117
2.118
2.119
2.120
2.121
2.121
2.121
2.121
2.121
2.121
2.121
2.121
2.121
15
15
15
15
15
20
20
20
20
20
20
20
10
15
0.3
0.3
0.3
0.3
0.3
0.2
0.4
0.8
0.8
0.2
0.2
0.2
0.2
0.3
77
51
96
100
77
55
78
94
50
75
-
-
51
70
50:50
85:15
57:43
80:20
91:9
94:6
92:8
88:12
86:14
92:8
-
-
95:5
95:5
Et
Et
Et
Et
Et
Et
Et
Et
Et
Et
Et
Et
i-Pr
i-Pr
Reactions were run at 80 °C with 0.4 mmol of phenol, 0.8 mmol of aldehyde, and 0.8 mmol of boronate for 24 
h in toluene unless otherwise indicated. [a] Yield of isolated product. [b] Enantiomeric ratios (er) determined by 
HPLC analysis using a chiral stationary phase. [c] Reaction was run for 48 h. [d] Reaction was run at 60 °C for 
24 h. [e] Ethanol used as solvent. [f] 1,4-Dioxane used as solvent. [g] Trifluorotoluene used as solvent.
+
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The reaction mixture concentration was observed to be directly proportional to the 
yield and inversely proportional to the enantiomeric ratio, likely due to a competing 
racemic background reaction rate (Table 2.1, Entries 6-8). The ideal temperature was 
found to be 80 °C, which was presumed to be high enough to promote the Friedel-Crafts 
hydroxy-alkylation condensation while at the same time maintaining moderate levels of 
enantioselectivity. Other solvents were examined in the reaction, but gave unfavorable 
results (Table 2.1, Entries 10-12). Next we turned our attention to the exchangeable ester 
groups of the boronate.117 In various platforms of boronate chemistry, it was found that 
bulkier boronate ester ligands can increase the steric bias in the transition state or effect 
the rate of exchange with chiral diol.11,118 It was found that changing the ethyl group to an 
isopropyl group provided a higher enantiomeric ratio (Table 2.1, Entry 13). Ultimately, 
conditions were identified to give product 2.114a in 70% yield and a 95:5 enantiomeric 
ratio (Table 2.1, Entry 14). These optimized conditions were carried forward to 
investigate the utility of the reaction. 
 
Scope of the Multicomponent Reaction 
 
Overall, the scope of the aldehyde and boronate components was tolerated in a 
variety of substrates, although the phenol was restricted to electron-rich substitution in 
order to promote the Friedel-Crafts hydroxy-alkylation condensation (Figure 2.22, Eq. 
35). In our first assessment, we probed the reactivity of the aldehyde component by 
looking at halogen substitution. The 4-position of the aldehyde was functionalized with 
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halogens giving rise to products with high yield and selectivity. Electron rich 4-
methoxybenzaldehyde maintained the previously observed enantioselectivity, although in 
modest yield 2.114d. Conversely, electron-deficient 4-(trifluoromethyl)-benzaldehyde 
gave a higher yield with moderate enantioselectivity 2.114e. These observations 
supported our hypothesis that the Friedel-Crafts hydroxy-alkylation condensation is the 
rate-determining step. Since, electron-deficient 4-(trifluoromethyl)-benzaldehyde is a 
more reactive electrophile, an increase of the uncatalyzed background reaction rate was 
expected.  Thus, the decrease in enantioselectivity of 2.114e is likely a consequence of 
competing reaction rates, catalyst controlled versus racemic background. Heterocyclic 
aldehydes could be used in the reaction, 2-thenaldehyde gave a quantitative yield 2.114f. 
Compound 2.114f was used to confirm the absolute stereochemistry of the products, 
which is consistent with the reported ortho-quinone methide mechanistic model of 
enantioselectivity.43 Additionally, 1- and 2-naphthaldehyde were tested in the reaction.  
2-Naphthaldehyde was well tolerated in the reaction providing 2.114g with high levels of 
yield and selectivity; however, 1-naphthaldehyde displayed lower reactivity 2.114h, 
likely due to an excess of steric bulk in the transition state. Notably, ortho-substitution 
significantly improved the stereoselectivity for 2-bromobenzaldehyde, furnishing 2.114i 
in 77% yield and 97:3 er. A similar observation was made with 2-methylbenzaldehyde 
product 2.114j, which is postulated to be the consequence of a key steric interaction in 
the enantio-determining event.  
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Figure 2.22 Scope of the multicomponent reaction. 
 
 Boronate 2.113, which was derived from its boronic acid precursor,1 was 
evaluated next and was found to work well for both styrenyl- and aryl boronates. Aryl 
boronate gave rise to a triarylmethane core 2.114l in 88% yield and 94:6 er. 
Enantioselective access to the triarylmethane core has been of recent interest due its 
significance in medicinal chemistry and materials science.119,120 Gratifyingly, electron 
deficient styrenyl boronate afforded product 2.114n in 73% yield with 94:6 er, despite 
being less nucleophilic. Unfortunately, highly reactive furanyl boronate furnished the 
product 2.114o in quantitative yield, but with low levels of selectivity. The use of 
hexenyl boronate gave product 2.114p with excellent results. 
Lastly, phenol substitution was investigated and revealed a limited scope, only 
providing product for electron rich substrates. 3-Methoxyphenol and 3,4-
dimethoxyphenol both provided typical results, furnishing products 2.114q and 2.114r 
with good yield and selectivity. Attempts to synthesize compound 2.114s met failure, 
giving no product formation. It appeared that a requisite for the Friedel-Crafts 
condensation to occur under these conditions is π-donation at the 3-position of the 
phenol. Subsequently, 3,5-dimethoxy phenol was investigated giving rise to racemic 
product 2.114t.  It is known that the ortho-quinone methide olefin adopts an E or Z 
conformation depending on the steric interactions of ortho-substituents. Substitution at 
the 5-position of the phenol created a steric bias towards a mixture of olefin geometries, 
which is likely responsible for the racemization of product.54,121 Combinations of 
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substrates were also tested furnishing products 2.114u-w with typical results, 
demonstrating the broad utility of this method. 
 
Cyclization of an Electron Rich Boronate 
 
 Electron rich boronate 4-methoxy styrenyl boronate was tested while exploring 
the scope of the reaction and displayed a propensity to cyclize, forming a 2,4-
diarylchroman structure. The chroman framework is an important structural motif found 
in many biologically active natural products;122–125 encouraged by this finding, we 
initiated studies to determine conditions selective for this unanticipated reaction pathway. 
 Using the previously optimized conditions with catalyst (R)-2.121 gave a 2:1 
product ratio favoring chroman 2.115a with a 55% yield and 79:21 er (Table 2.2, Entry 
3). Other functionalized BINOL chiral catalysts promoted the desired reaction pathway, 
but (R)-3,3’-I2-BINOL (R)-2.122 performed best with high chemo- and enantioselectivity 
(Table 2.2, Entry 4). Thus, we turned our attention to the reaction conditions to further 
optimize the results. We postulated that it was the electron-rich nature of the styrene in 
combination with the acidic conditions at high temperatures that facilitated the 
cyclization event. To determine this experimentally, the reaction was run in a sealed tube 
at 120 °C for 24 hours.  A significant shift in chemoselectivity was observed favoring the 
cyclization in about a 14:1 ratio in good yield (Table 2.2, Entry 7). Pushing this idea 
further, the temperature was raised to 150 °C, forming exclusively chroman product 
2.115a. Prolonged high temperatures were found to erode the stereochemistry in the 
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reaction.  We found that a brief increase in temperature following the standard reaction 
conditions afforded the product in good yield and selectivity (Table 2.2, Entry 8). 
Recrystallization from hot hexanes was found to enhance the stereochemistry of the 
product, giving 2.115a in 40% overall yield, 99:1 er, and >20:1 dr (Table 2.2, Entry 9). A 
few experiments were run in order to examine the potential of this cyclization strategy. 
 
Table 2.2 Screening for chemoselective formation of chroman. 
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A variety of electron-rich styrenyl boronates were tested and cyclized under the 
designed conditions (Figure 2.23, Eq. 36). The aldehyde component behaved similar to 
the initial multicomponent reaction; electron deficient product 2.115b gave higher yields 
while electron rich substrates 2.115c were lower, with 72% and 49% yields respectively.  
Interestingly, product 2.115b performed well in terms of enantioselectivity with an 89:11 
er whereas product 2.115c showed poor selectivity with a 76:24 er, which is opposite to 
the trend observed in the multicomponent reaction. This observation can be rationalized 
through observations made by Rokita, which indicated that the stability of ortho-quinone 
methide formation is associated with electron donating substituents.29 Accordingly, 
product 2.115c can re-form a stabilized ortho-quinone methide in situ with erosion of 
stereochemistry, while the ortho-quinone methide derivative of 2.115b is less stabilized. 
Paraformaldehyde was examined in the reaction giving product 2.115e in 51% yield and 
60:40 er, which suggests that other non-aromatic aldehydes may work in these 
multicomponent reactions as well.  Neutral styrenyl boronate was tested for reactivity, 
requiring 24 h of heating at 150 °C to obtain product 2.115f in 32% yield, 85:15 er, and 
20:1 dr without recrystallization. This interesting result supported our hypothesis that the 
cyclization is facilitated by the electron-rich functionality paired with high reaction 
temperatures.  Additionally, the enantioselectivity was preserved after 24 h of high 
temperatures, which indicates that electron-neutral and deficient substituents on the 
chroman products 2.115 act to prevent re-entry into the ortho-quinone methide 
intermediate. 
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Figure 2.23 Scope of the cyclization cascade. 
 
Cyclization Study 
 
 An experimental study was carried out to further investigate the nature of the 
cyclization. Enantioenriched product (S)-2.114x was isolated and subjected to the 
cyclization conditions used to afford chroman products, but in the absence of phenol 
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starting material 2.111a (Figure 2.24, Eq. 37). After 24 hours at 150 °C, a modest 
quantity of cyclization was observed furnishing chroman product (R,S)-2.115a with an 
increased enantiomeric ratio (90:10 er). Starting material (S)-2.114x was recovered in a 
69% yield, also with an increased enantiomeric ratio (87:13 er). This result demonstrated 
a stepwise pathway leading to the formation of chroman product (R,S)-2.115 with 
enhanced selectivity in the cyclization step being facilitated by catalyst. The enantiomer 
of the catalyst (R)-2.122 used in this study was the same as in the multicomponent 
boronate addition, which indicated a matched scenario for the enantiodetermining events. 
A second reaction was run under the same exact conditions, this time replacing (S)-
2.114x with (R)-2.114x (Figure 2.24, Eq. 38). In this case, catalyst (R)-2.122 provided 
chroman product (R,S)-2.115a again, previously observed in Figure 2.24, Equation 27. 
Starting material (±)-2.114x was recovered in a 68% yield with complete racemization of 
the stereocenter. This result indicates a racemization pathway of starting material (R)-
2.114x. This racemization is likely assisted by catalyst (R)-2.122, although racemization 
from a chiral complex of product and/or starting material was not been ruled out.  
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Figure 2.24 Cyclization study. 
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Mechanism of the Multicomponent Reaction 
 
A mechanism of the asymmetric, multicomponent reaction has been proposed that 
is consistent our experimental observations (Scheme 2.25, Eq. 39). The Friedel-Crafts 
hydroxy-alkylation condensation is rate-limiting and facilitated by boronate in a 
regiospecific process, furnishing dioxaborin complex 2.126. This assertion is reasonable 
given that the multicomponent reaction does not proceed at lower temperatures and the 
electrophilicity of the aldehyde component dictates the rate of product formation. 
Additionally, condensation of the aldehyde occurs ortho to the phenol group, which is 
consistent with previous observations made in the literature.37,38,110 After the formation of 
dioxaborin 2.126, dissociation of the benzylic alcohol with ligand transfer occurs rapidly 
to form product 2.127 in the enantiodetermining event. Ligand transfer is a facile process 
accelerated by chiral biphenols, consistent with our earlier studies in which additions of 
boronates to in situ generated ortho-quinone methides occur at low temperatures.43 The 
ease of ligand transfer also explains why a dioxaborin intermediate is not observed during 
the reaction. Next, cyclization is initiated by protonation of the electron-rich styrenyl 
functionality forming intermediate 2.128, which is stabilized through resonance.  
Nucleophilic attack from the phenol oxygen occurs rapidly to form chroman product 
2.115. 
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Figure 2.25 Mechanism proposed for the asymmetric boronate multicomponent 
reaction. 
 
Figure 2.26 1D NOE data reveals cis relationship. 
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The experimentally observed stereochemistry in the enantioselective 
multicomponent condensation reaction was determined by analogy to known substrate 
(S)-2.114f.43 One dimensional NOE revealed a cis relationship in the cyclized product 
2.115c. Proton Hb of 2.115c was irradiated using an Agilent 500 MHz NMR 
spectrometer providing a nuclear overhauser effect of >5% in proton Ha (Figure 2.26). 
The cyclization study indicated catalyst (R)-2.122 to be a matched case for the boronate 
addition and cyclization scenario, which was used to determined the absolute 
stereochemistry of the product (R,S)-2.115c as indicated. 
 
Proposed Transition State  
 
The proposed transition state model for the enantioselective multicomponent 
condensation reaction is in agreement with our previously published boronate chemistry 
whereby the alkoxy-ligand and chiral biphenol are both bound to boron in the enantio-
determining event (Figure 2.27).22,23,35,43,126 A cyclic dioxaborin complex is generated 
from the boron-mediated Friedel-Crafts hydroxy-alkylation step, which exists as a 
mixture of conformations 2.129a and 2.129b in equilibrium. The bound chiral diol 
facilitates extrusion of the hydroxyl group via hydrogen bonding to form an ortho-
quinone methide intermediate. Rotation of the benzylic carbon bond is a requirement for 
ortho-quinone methide formation, which ensures a proper orbital alignment for linear 
conjugation. There is a preference for (E)-olefin geometry that acts to minimize sterics 
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with the quinone oxygen.26 The formation of (E)-ortho-quinone methide in complex 
2.130a is less favorable as it builds sterics in the transition state and leads to the minor 
enantiomer of product. In contrast, formation of (E)-ortho-quinone methide in complex 
2.130b is a facile process with delivery of the nucleophile to the si face of the methide 
carbon to provide the experimentally observed major (S)-enantiomer of product. 
 
 
Figure 2.27 Proposed transition state model of enantioselectivity.  
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Conclusion 
  
The usefulness of ortho-quinone methides in synthesis has been associated with 
their methods of formation. A bench stable ortho-quinone methide synthesized by Jurd 
allowed for a variety asymmetric transformations to be developed.44,68 Our group was 
able to demonstrate the enantioselective addition of boronates to bench stable ortho-
quinone methides using chiral biphenol catalysis. The scope of the reaction was increased 
substantially by implementing benzylic alcohol starting materials as bench stable ortho-
quinone methide precursors. In these examples, non-stabilized ortho-quinone methides 
were formed in situ to under mildly acidic conditions. Since then, transformations of in 
situ generated ortho-quinone methides from benzylic alcohols have been demonstrated by 
a variety groups, which provided a range of interesting scaffolds with high stereocontrol. 
As demonstrated, the in situ synthesis of ortho-quinone methides is an attractive 
approach to alleviate issues involved in constructing a reactive intermediate.  
A multicomponent condensation reaction was developed to form ortho-quinone 
methides through a bimolecular process involving a phenol and aldehyde, mediated by 
boronates and catalyzed by chiral biphenols. This reaction provided access to di- and 
triaryl methane products with high levels of yield and enantioselectivity from 
commercially available starting materials. In addition to the di- and triaryl methane 
products, a cyclization pathway was discovered leading to 2,4-diaryl chroman products 
with useful levels of enantio- and diastereoselectivity. The ability of this multicomponent 
reaction to access reactive ortho-quinone methide intermediates from bench stable, 
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commercially available starting materials prompted us to extend this methodology toward 
asymmetric cycloadditions with electron rich dienophiles. 	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Experimental 	  
General Information  	  
All 1H NMR, and 13C NMR spectra were recorded using a Varian 500 MHz VNMR 
spectrometer at ambient temperature in CDCl3. Chemical shifts are reported in parts per 
million as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broad), coupling constant, and integration. Infrared spectra 
were recorded on a Nicolet FT-IR with ATR. Optical rotations were recorded on a 
Rudolph Autopol II polarimeter at 25°C, and were reported as [α]D (conventional).  
Optical rotations for chroman substrates were reported as diastereomeric mixtures. 
Analytical thin layer chromatography was performed using Sorbent Technologies silica 
gel HL TLC plates (UV 254 nm, 250 µm). Flash column chromatography was performed 
on ZEOprep 60 ECO 40-63 academic grade silica gel. Chiral HPLC analysis was 
performed using an Agilent 1100 series HPLC with a diode array detector. Chiral 
columns include Chiralcel®OD (Chiral Technologies Inc., 24cm×4.6mm I.D.) and 
Chiralpak®AD-H (Chiral Technologies Inc., 25cm × 4.6 mm I.D.) and Chiralpak®IA 
(Daicel Chemical Industries, LTD., 25cm × 4.6 mm). High-resolution mass spectra were 
obtained in the Boston University Chemical Instrumentation Center using a Waters Q-
TOF mass spectrometer. All reactions were performed under argon, in oven-dried 
glassware with magnetic stirring. (R)-BINOL and (S)-BINOL were purchased from 
STREM and used without further purification; (R)-VANOL was purchased from Aldrich 
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and used without further purification. All BINOL derivatives were prepared according to 
known literature procedures.1 All starting materials were purchased from Aldrich and 
used as is unless otherwise noted. 
 
General Procedures 
 
 
General procedure for the preparation of (E)-styryl boronic acid: To a flame dried 150 
mL round bottom flask purged with argon and equipped with a magnetic stir bar was 
added phenyl acetylene (19.5 grams, 0.190 mol) via syringe at 0°C.  To this with stirring 
was added catechol borane (22.9 grams, 0.190 mol) via syringe, slowly.  This was 
warmed to room temperature and then heated to 70°C for an hour.  Afterwards, the 
reaction mixture was cooled to room temperature and was quenched with approximately 
75 mL of water.  The heterogenous mixture was then heated to boiling and the hot 
resultant was filtered off through cotton.  Upon cooling, crystals in filtrate were filtered 
off to yield pure (E)-styryl boronic acid. 
 
O
HB
O
1. Acetylene then 
Borane 0°C-25°C
2. 70°C 1 hour
3. H2O heat 15 min B OH
OH
+
(E)-styrenyl 
boronic acid
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General procedure for the preparation of (E)-diisopropyl boronates (2.113): To a flame 
dried 250 mL round bottom flask equipped with a magnetic stir bar was added 15 grams 
of oven dried magnesium sulfate, 15 grams of 4Å molecular sieves, and 1.5 grams (10.1 
mmol) of (E)-styrylboronic acid.  To the mixture was added 30 mL of isopropyl alcohol 
and 50 mL of chloroform.  This was set to reflux in a heating mantle for 24 hours.  
Afterwards, drying agents were removed via vacuum filtration under an argon blanket.  
The filtrate was collected and concentrated via rotatory evaporation.  The concentrated 
filtrate was placed into an oven dried amber vial equipped with stir bar under high 
vacuum and magnetic stirring in order to remove residual isopropyl alcohol.  A 2M 
solution of boronate was prepared by diluting with anhydrous toluene performed under an 
argon environment.  Prepared boronates were stored under argon and kept in a -20°C 
freezer. 
 
 
B OH
OH
B O
O
MgSO4, 4Å MS
iPrOH, CHCl3
reflux 24 h
2.113a
(E)-styrenyl 
boronic acid
OH
O
O
O
H
B
OiPr
OiPr+
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O
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0.4 mmol 0.8 mmol 0.8 mmol
+
15 mol % 
(R)-2.121
PhCH3
80 °C, 24 h
2.111a 2.112a
2.114a, 70% yield 95:5 er
2.113a
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General procedure for the enantioselective multicomponent condensation reactions of 
phenols, aldehydes, and boronates catalyzed by chiral biphenols (2.114): To an oven 
dried reaction tube equipped with stir bar was added sesamol (0.40 mmol, 55.2 mg) and 
(R)-Br2BINOL (0.12 mmol, 53.0 mg) followed by benzaldehyde (0.80 mmol, 81.5 µL) 
via microsyringe.  The mixture was capped, evacuated under vacuum, and purged with 
argon.  To this mixture was added toluene (0.93 mL) and 2M boronate solution (0.80 
mmol, 0.4 mL).  An argon balloon was then attached, and this was set to stir on a metal 
reaction block at 80°C for 24 hours unless otherwise indicated.  The reaction was purified 
without work up via flash chromatography over a silica gel column (0-10% ethyl acetate 
in hexanes) to afford the product 2.114a as a colorless oil (92.5 mg, 70% yield).  The 
product tends to decompose if left open to air at room temperature..  In order to achieve 
racemic product for HPLC traces, racemic Br2BINOL was used in the reaction, instead. 
 
 
General procedure for the asymmetric multicomponent cyclization of electron rich 
paramethoxy styrenyl boronate (2.115a) : To an oven dried sealed tube containing a stir 
bar was added sesamol (0.40 mmol, 55.2 mg) and (R)-I2BINOL (0.12 mmol, 65.0 mg) 
followed by benzaldehyde (0.40 mmol, 40.3 µL) via microsyringe.  To this mixture was 
O
O O
O
2.115a, 72% yield, 85:15 er, 2.4:1 dr
recrystallized: 40% overall yield 
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added 0.93 mL toluene (0.3M) and paramethoxy styrenyl boronate.  Immediately 
afterwards, the tube was flushed with argon gas, sealed, and placed in an oil bath at 80°C 
for 24 hours.  Afterwards, the oil bath temperature was raised to 150°C for 1 hour.  The 
reaction was then taken off heat and allowed to cool to ambient temperature.  The 
reaction mixture was purified directly via column chromatography in neutral alumina to 
yield pure product as a mixture of diastereomers.  Recrystallization was done using hot 
hexanes. 
 
 
Procedure for cyclization study:  Part 1. The general procedure for the enantioselective 
multicomponent condensation reactions of phenols, aldehydes, and boronates catalyzed 
by chiral biphenol (R)-2.121 was followed first to obtain isolated (S)-2.114x in 17% yield 
and 81:19 er. Part 2. To an oven dried reaction tube containing a stir bar was added (S)-
2.114x (49 mg, 0.14 mmol), (R)-I2BINOL (R)-117 (22 mg, 0.30 equiv.) and 
O
O
O
(S)
15 mol % (R)-2.122
PhCH3 150°C, 24 h
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O O
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OCH3
(S)-2.114x
81:19 er
OH
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69% recovery
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(S)-2.114x
O
2.112a
H
B
i-PrO
i-PrO
2.113x OCH3
+
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benzaldehyde 2.122a (29 µL, 2.0 equiv.) via microsyringe. Toluene (0.32 mL) was then 
added to the mixture and the reaction vessel was flushed with argon. Under a stream of 
argon, boronate (0.14 mL, 2.0 equiv.) 2.123x was added via syringe and the tube was 
quickly sealed and placed in an oil bath at 150 °C for 24 hours. The reaction was then 
taken off heat and allowed to cool to ambient temperature.  The reaction mixture was 
purified directly via column chromatography with silica gel to afford (S)-2.114x (69% 
recovery, 87:13 er) and (R,S)-2.115a (18% yield, 90:10 er, 2:1 dr). 
  
 
Procedure for cyclization study: Part II. The opposite enantiomer of catalyst, (S)-2.121, 
was used in the general procedure for the enantioselective multicomponent condensation 
reactions of phenols, aldehydes, and boronates described in Part 1 to obtain (R)-2.114x 
with 81:19 er. Compound (R)-2.114x was then subjected to the exact same protocol 
O
O
O
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O
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described in Part 2.  In this case, product (±)-2.114x was recovered in 68% yield with 
50:50 er and chroman (R,S)-2.115a was isolated in 11% yield, 85:15 er, and 2:1 dr. 
  
 
Characterization Data 
 
(S,E)-6-(1,3-diphenylallyl)benzo[d][1,3]dioxol-5-ol (2.114a): The general procedure for 
the asymmetric multicomponent addition of boronates to in situ generated ortho-quinone 
methides.  The crude mixture was purified by flash column chromatography with elution 
from 0%-10% ethyl acetate in hexane. Yield: 70%. Enantiomeric Ratio: 95:5. [α]D (c 
1.0M, CHCl3): +11.6°. HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., 
Hexanes:IPA = 95:05, 1.0mL/min. tr major: 35.1 min., tr minor: 41.2 min. 1H NMR (500 
MHz, CDCl3): δ 7.35 – 7.04 (m, 12H), 6.55 (dd, J = 15.9, 7.0 Hz, 1H), 6.51 (s, 1H), 6.36 
(d, J = 1.0 Hz, 1H), 6.28 (d, J = 15.9 Hz, 1H), 5.84 – 5.80 (m, 2H), 4.95 (d, J = 7.0 Hz, 
1H), 4.46 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 148.00, 146.77, 141.89, 141.74, 
136.87, 131.89, 130.98, 128.78, 128.55, 128.54, 127.54, 126.92, 126.37, 121.41, 108.93, 
101.10, 99.11, 77.25, 77.00, 76.74, 48.16. IR (thin film, cm-1): 1733.8, 1717.1, 1700.1, 
1684.0, 1652.9, 1558.7, 1540.3, 1521.3, 1506.2, 1488.4, 1456.8, 1436.5, 1219.6, 1164.9, 
1037.7, 772.2 MS (m/z): calculated for [C22H18O3H+]: 330.1 m/z; found 330.1 m/z.  
 
(S,E)-6-(1-(4-bromophenyl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114b): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
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generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0%-15% ethyl acetate in hexane. Yield: 68% 
Enantiomeric Ratio: 95:5 [α]D (c 1.0M, CHCl3): +6.0°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 37.2 min., tr 
minor: 54.0 min. 1H NMR (500 MHz, CDCl3): δ 7.47 – 6.94 (m, 9H), 6.50 (dd, J = 15.8, 
6.9, 1H), 6.49 (s, 1H), 6.34 (s, 1H), 6.25 (d, J = 16.0 Hz, 1H), 5.82 (dd, J = 4.3, 1.3 Hz, 
1H), 4.95 (d, J = 6.8 Hz, 1H), 4.43 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 147.74, 
146.84, 141.83, 141.27, 136.70, 132.15, 131.70, 130.58, 130.32, 128.59, 127.66, 126.37, 
120.97, 120.66, 108.82, 101.19, 98.99, 77.26, 77.01, 76.76, 47.24. IR (thin film, cm-1): 
2361.6, 2337.3, 1716.7, 1699.9, 1684.6, 1558.47, 1540.45, 1505.28, 1436.29, 1166.31, 
1037.49. MS (m/z): calculated for [C22H17BrO3H+]: 409.0, 411.0 m/z; found 409.3, 
411.3 m/z. 
 
(S,E)-6-(1-(4-fluorophenyl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114c): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 63% 
Enantiomeric Ratio: 95:5 [α]D (c 1.0M, CHCl3): +9.7° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 34.2 min., tr 
minor: 46.1 min.1H NMR (500 MHz, CDCl3): δ 7.30 – 7.24 (m, 2H), 7.23 – 7.17 (m, 
2H), 7.16 – 7.09 (m, 3H), 6.95 – 6.88 (m, 2H), 6.49 (dd, J = 15.9, 6.9 Hz, 1H), 6.48 (s, 
1H), 6.32 (s, 1H), 6.22 (d, J = 15.9 Hz, 1H), 5.78 (d, J = 4.0 Hz, 1H), 4.95 (d, J = 6.8 Hz, 
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1H), 4.63 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 162.68, 160.73, 147.84, 146.78, 
141.78, 137.87, 136.83, 131.93, 131.07, 130.10, 130.04, 128.60, 127.62, 126.39, 121.39, 
115.56, 115.39, 108.86, 101.16, 99.02, 77.31, 77.05, 76.80, 47.07. IR (thin film, cm-1): 
3853.5, 3747.6, 3481.6, 2361.6, 2337.3, 1699.3, 1651.9, 1558.4, 1540.3, 1505.2, 1486.30, 
1436.66, 1276.9, 1223.7, 1165.0, 1037.9, 933.7, 833.2. MS (m/z): calculated for 
[C22H17FO3H+]: 349.1 m/z; found 349.3 m/z.  
 
(S,E)-6-(1-(4-methoxyphenyl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114d): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-20% ethyl acetate in hexanes. Yield: 44% 
Enantiomeric Ratio: 95:5. [α]D (c 1.0M, CHCl3): +9.3°. HPLC Analysis: Chiralcel OD 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 11.5 min., tr 
minor: 14.7 min. 1H NMR (500 MHz, CDCl3): δ 7.32 – 7.07 (m, 7H), 6.80 (d, J = 8.6 
Hz, 2H), 6.52 (dd, J = 15.9, 7.0 Hz, 1H), 6.51 (s, 1H), 6.35 (s, 1H), 6.25, (d, J = 15.9 Hz, 
1H), 5.80 (d, J = 4.1 Hz, 2H), 4.88 (d, J = 7.0 Hz, 1H), 4.54 (s, 1H), 3.72 (s, 3H).  
13C NMR (126 MHz, CDCl3): δ 158.54, 148.05, 146.74, 141.68, 136.92, 133.69, 131.66, 
131.27, 129.56, 128.54, 127.50, 126.37, 121.60, 114.22, 108.87, 101.08, 99.12, 77.27, 
77.02, 76.76, 55.29, 47.47.  IR (thin film, cm-1): 3853.5, 3747.6, 2361.6, 2337.4, 1734.7, 
1716.7, 1699.2, 1684.6, 1652.1, 1588.4, 1540.4, 1507.4, 1457.48, 1167.8, 1036.7, 667.7.  
MS (m/z): calculated for [C23H2O4H+]: 361.1 m/z; found 361.4 m/z.  
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(S,E)-6-(3-phenyl-1-(4-(trifluoromethyl)phenyl)allyl)benzo[d][1,3]dioxol-5-ol (2.114e): 
The general procedure for the asymmetric multicomponent addition of boronates to in 
situ generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-20% ethyl acetate in hexanes. Yield: 83% 
Enantiomeric Ratio: 91:9. [α]D (c 1.0M, CHCl3): +15.6°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 14.6 min., tr 
minor: 21.0 min. 1H NMR (500 MHz, CDCl3): δ 7.61 – 7.56 (m, 2H), 7.42 – 7.35 (m, 
3H), 7.34 – 7.22 (m, 3H), 6.65 (overlap, 2H), 6.42 (s, 1H), 6.35 (d, J = 15.9 Hz, 1H), 5.91 
(dd, J = 4.8, 1.3Hz, 2H), 5.16 (d, J = 7.0 Hz,  1H), 4.56 (s, 1H). 13C NMR (126 MHz, 
CDCl3): δ 147.69, 146.89, 146.67, 141.90, 136.68, 132.38, 130.39, 129.04, 128.88, 
128.85, 128.83, 128.78, 128.60, 128.49, 127.71, 126.49, 126.38, 125.52, 125.49, 125.46, 
125.43, 125.28, 123.12, 120.82, 108.82, 101.23, 98.93, 77.26, 77.00, 76.75, 47.46. IR 
(thin film, cm-1):  3853.5, 3837.8, 3819.3, 3747.7, 3673.9, 3649.5, 3629.1, 2361.57, 
2337.5, 1699.4, 1651.86, 1558.4, 1505.3, 1488.2, 1436.8, 1325.9, 1165.2, 1122.5, 1067.6, 
1038.6. MS (m/z): calculated for [C23H17F3O3H+]: 399.1 m/z; found 399.4 m/z.  
 
(R,E)-6-(3-phenyl-1-(thiophen-2-yl)allyl)benzo[d][1,3]dioxol-5-ol (2.114f): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 100% 
Enantiomeric Ratio: 92:8 [α]D (c 1.0M, CHCl3): +9.2°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 20.3 min., tr 
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minor: 22.0 min. 1H NMR (500 MHz, CDCl3): δ 7.42 – 7.20 (m, 6H), 6.99 (ddd, J = 5.1, 
3.5, 1.4 Hz, 1H), 6.92 – 6.89 (m, 1H), 6.68 (d, J = 1.4 Hz, 1H), 6.63 (ddd, J = 15.8, 7.1, 
1.5 Hz, 1H), 6.47 (d, J = 15.6 Hz, 1H), 5.91 (s, 2H), 5.25 (d, J = 7.0 Hz, 1H), 4.64 (s, 
1H). 13C NMR (126 MHz, CDCl3): δ 147.88, 147.07, 146.22, 141.82, 136.72, 132.77, 
131.71, 130.29, 128.58, 128.55, 127.65, 127.58, 127.40, 126.94, 126.49, 125.36, 124.94, 
124.86, 124.63, 121.23, 108.56, 101.18, 99.16, 77.26, 77.21, 77.01, 76.75, 43.77.  IR 
(thin film, cm-1): 3853.3, 3837.6, 3747.4, 3673.6, 3649.0, 3446.8, 1651.1, 1558.3, 
1503.7, 1483.9, 1435.7, 1167.0, 1037.3. MS (m/z): calculated for [C20H16O3SH+]: 
337.1 m/z; found 337.2 m/z.  
 
(S,E)-6-(1-(naphthalen-2-yl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114g): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-10% ethyl acetate in hexanes. Yield: 87% 
Enantiomeric Ratio: 94:6 [α]D (c 1.0M, CHCl3): -1.06°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 26.5 min., tr 
minor: 34.8 min. 1H NMR (500 MHz, CDCl3): δ 7.86 – 7.75 (m, 3H), 7.71 (s, 1H), 7.51-
7.41 (m, 2H), 7.42-7.36 (m, 3H), 7.34-7.29 (m, 2H), 7.27-7.21 (m, 1H), 6.72 (dd, J = 
16.0, 7.0 Hz, 1H), 6.64 (s, 1H), 6.45 (s, 1H), 6.40 (dd, J = 16.0, 1.2 Hz, 1H), 5.90 (dd, J = 
3.7, 1.3 Hz, 2H), 5.21 (d, J = 7.0 Hz, 1H), 4.62 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 
148.11, 146.85, 141.80, 139.49, 136.88, 133.51, 132.45, 132.13, 130.86, 128.57, 128.48, 
127.83, 127.63, 127.58, 127.16, 126.72, 126.43, 126.42, 126.19, 125.84, 121.25, 109.04, 
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101.13, 99.13, 77.26, 77.00, 76.75, 48.19. IR (thin film, cm-1): 3902.3, 3853.5, 3837.8 
3819.5, 3802.4, 3747.8, 3710.9, 3680.6, 3674.0, 3649.4, 3629.1, 2361.4, 2338.3, 1734.8, 
1716.7, 1699.5, 1684.5, 1651.8, 1635.4, 1558.3, 1540.6, 1506.0, 1457.4, 1435.9, 1167.6, 
1037.6, 667.8. MS (m/z): calculated for [C26H20O3H+]: 381.1 m/z; found 381.3 m/z.  
 
(S,E)-6-(1-(naphthalen-1-yl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114h): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes.Yield: 52% 
Enantiomeric Ratio: 93:7 [α]D (c 1.0M, CHCl3): -83.8° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 26.4 min., tr 
minor: 22.3 min.1H NMR (500 MHz, CDCl3): δ 7.97-8.06 (m, 1H), 7.85-7.91 (m, 1H), 
7.77-7.84 (m, 1H), 7.41-7.51 (m, 4H), 7.35-7.41 (m, 2H), 7.27-7.34 (m, 2H), 7.20-7.26 
(m, 1H), 6.74 (dd, J = 16.0, 6.4 Hz, 1H), 6.48 (s, 1H), 6.44 (s, 1H), 6.32 (dd, J = 16.0, 1.3 
Hz, 1H), 5.85 (dd, J = 21.2, 1.3 Hz, 2H), 5.81 (d, J = 5.5 Hz, 1H), 4.73 (s, 1H).13C NMR 
(126 MHz, CDCl3): δ 147.72, 146.74, 141.80, 138.10, 136.92, 134.09, 132.02, 131.68, 
131.06, 128.78, 128.54, 127.85, 127.52, 126.40, 126.31, 126.05, 125.68, 125.38, 123.93, 
121.15, 109.05, 101.06, 98.92, 77.26, 77.01, 76.75, 43.51.IR (thin film, cm-1): 3025.2, 
1597.3, 1502.5, 1484.2, 1436.6, 1396.7, 1167.0, 1038.0, 972.0, 934.7 MS (m/z): 
calculated for [C26H20O3H+]: 381.1 m/z; found 381.1 m/z. 
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(R,E)-6-(1-(2-bromophenyl)-3-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114i): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 5-20% ethyl acetate in hexanes.  
Yield: 77% Enantiomeric Ratio: 97:3 [α]D (c 1.0M, CHCl3): -12.4° HPLC Analysis: 
Chiralpak IA column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 
30.7 min., tr minor: 57.9 min.1H NMR (500 MHz, CDCl3): δ 7.51 (d, J = 8.0 Hz, 1H), 
7.28 (d, J = 7.6 Hz, 2H), 7.25-7.11 (m, 5H), 7.08-7.02 (m, 1H), 6.46 (dd, J = 16.0, 6.2 Hz, 
1H), 6.40 (s, 1H), 6.37 (s, 1H), 6.17 (d, J = 16.0 Hz, 1H), 5.81 (d, J = 6.3 Hz, 2H), 5.34 
(d, J = 6.2 Hz, 1H), 4.62 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 148.20, 146.84, 
141.70, 141.32, 136.79, 133.25, 132.29, 130.22, 129.98, 128.56, 128.45, 127.61, 127.60, 
126.42, 125.18, 120.10, 108.72, 101.13, 98.96, 77.27, 77.02, 76.76, 46.93. IR (thin film, 
cm-1): 2361.6, 2337.3, 1716.7, 1699.3, 1684.6, 1652.0, 1558.5, 1540.5, 1505.3, 1436.3, 
1166.3, 1037.5, 667.9. MS (m/z): calculated for [C22H17BrO3H+]: 409.0, 411.0 m/z; 
found 409.3, 411.3 m/z.  
 
(S,E)-6-(3-phenyl-1-(o-tolyl)allyl)benzo[d][1,3]dioxol-5-ol (2.114j): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-10% ethyl acetate in hexanes. Yield: 47% 
Enantiomeric Ratio: 98:2 [α]D (c 1.0M, CHCl3): -18.9°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 26.9 min., tr 
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minor: 41.9 min.1H NMR (500 MHz, CDCl3): δ 7.41-7.37 (m, 2H), 7.35-7.29 (m, 2H), 
7.27-7.20 (m, 5H), 6.62 (dd, J = 16.0, 6.5 Hz, 1H), 6.51 (s, 1H), 6.45 (s, 1H), 6.27 (dd, J 
= 16.0, 1.5 Hz, 1H), 5.91 – 5.88 (m, 1H), 5.20 (dd, J = 6.5, 1.6 Hz, 1H), 4.76 (s, 1H), 2.31 
(s, 3H). 13C NMR (126 MHz, CDCl3): δ 148.08, 146.64, 141.71, 140.22, 136.99, 
136.77, 131.61, 130.92, 130.78, 128.57, 128.18, 127.50, 126.97, 126.39, 126.27, 120.96, 
108.93, 101.07, 98.92, 77.32, 77.06, 76.81, 44.23, 19.47. IR (thin film, cm-1): 3853.5, 
3837.9, 3747.9, 3674.1, 3649.3, 3629.1, 2361.24, 2339.4, 1734.8, 1716.7, 1684.4, 1651.4, 
1558.3, 1540.9, 1506.7, 1457.6, 1165.7, 1037.8, 771.8, 667.8. MS (m/z): calculated for 
[C23H20O3H+]: 345.1 m/z; found 345.2 m/z. 
 
(S,E)-6-(3-(4-fluorophenyl)-1-phenylallyl)benzo[d][1,3]dioxol-5-ol (2.114k): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 65% 
Enantiomeric Ratio: 90:10 [α]D (c 1.0M, CHCl3): +11.5°. HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 43.8 min., tr 
minor: 56.0 min.1H NMR (500 MHz, CDCl3): δ 7.40-7.21 (m, 7H), 6.99 (t, J = 8.7 Hz, 
2H), 6.60 (s, 1H), 6.55 (dd, J = 15.9, 7.0 Hz, 1H), 6.43 (s, 1H), 6.31 (d, J = 15.7 Hz, 1H), 
5.89 (dd, J = 5.2, 1.3 Hz, 2H), 5.04 (d, J = 7.0 Hz, 1H), 4.60 (s, 1H). 13C NMR (126 
MHz, CDCl3): δ 163.24, 161.27, 147.93, 146.76, 141.94, 141.74, 133.10, 133.07, 130.87, 
130.85, 130.65, 128.78, 128.52, 127.89, 127.83, 126.93, 121.40, 115.51, 115.34, 108.92, 
101.12, 99.08, 77.27, 77.02, 76.77, 47.99. IR (thin film, cm-1): 3853.5, 3837.8, 3819.3, 
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3802.4, 3747.7, 3711.0, 3689.5, 3673.9, 3649.4, 3629.1, 3587.7, 2361.5, 2337.8, 1771.4, 
1734.68, 1716.7, 1699.4, 1684.5, 1652.0, 1635.6, 1558.3, 1540.6, 1520.8, 1507.3, 1473.8, 
1457.4, 1436.0, 1396.5, 1222.7. MS (m/z):  calculated for [C22H17FO3H+]: 349.1 m/z; 
found 349.3 m/z. 
 
(R)-6-((4-methoxyphenyl)(phenyl)methyl)benzo[d][1,3]dioxol-5-ol (2.114l): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 88% 
Enantiomeric Ratio: 94:6 [α]D (c 1.0M, CHCl3): -8.4° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 71.3 min., tr 
minor: 66.4 min. 1H NMR (400 MHz, CDCl3): δ 7.36-7.21 (m, 3H), 7.13 (d, J = 7.5 Hz, 
1H), 7.06 (d, J = 8.8 Hz, 1H), 6.86 (d, J = 8.7 Hz, 1H), 6.42 (s, 1H), 6.28 (s, 1H), 5.87 (s, 
2H), 5.58 (s, 1H), 4.05 (s, 1H), 3.80 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 158.38, 
147.94, 146.56, 142.77, 141.47, 134.37, 130.23, 129.18, 129.18, 128.60, 128.58, 126.70, 
122.87, 114.05, 109.69, 101.02, 98.91, 77.28, 77.12, 77.02, 76.87, 76.77, 76.61, 55.25, 
49.95. IR (thin film, cm-1): 3868.4, 3853.3, 3837.5, 3819.0, 3802.2, 3747.5, 3710.8, 
3688.9, 3673.5, 3649.2, 3628.9, 3587.1, 3587.1, 3445.6, 2898.9, 2361.4, 2337.0, 1507.4, 
1486.6, 1456.6, 1436.4, 1397.5, 1245.7, 1177.0, 1036.5, 934.0, 879.5, 746.8, 700.6, 
667.8. MS (m/z): calculated for [C21H18O4H+]: 335.1 m/z; found 335.1 m/z  
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(S)-6-(benzo[b]thiophen-2-yl(phenyl)methyl)benzo[d][1,3]dioxol-5-ol (2.114m): The 
general procedure for the asymmetric multicomponent addition of boronates to in situ 
generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 95% 
Enantiomeric Ratio: 93:7 [α]D (c 1.0M, CHCl3): -7.1° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 51.6 min., tr 
minor: 48.8min. 1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.4 Hz, 1H), 7.64 (d, J = 7.0 
Hz, 1H), 7.39-7.24 (m, 7H), 6.92 (s, 1H), 6.53 (s, 1H), 6.42 (s, 1H), 5.92 (s, 1H), 5.89 
(dd, 5.5, 1.4 Hz, 2H), 4.59 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 147.85, 147.74, 
147.00, 141.92, 141.74, 140.04, 139.63, 128.85, 128.68, 127.19, 124.23, 124.02, 123.29, 
123.23, 122.20, 121.93, 109.28, 101.20, 98.88, 77.28, 77.02, 76.77, 46.31. IR (thin film, 
cm-1): 1845.1, 1823.5, 1699.8, 1655.2, 1542.2, 1166.1, 1120.9. MS (m/z): calculated for 
[C22H16O3SH+]: 361.1 m/z; found 361.1 m/z. 
 
(S,E)-6-(1-phenyl-3-(4-(trifluoromethyl)phenyl)allyl)benzo[d][1,3]dioxol-5-ol (2.114n): 
The general procedure for the asymmetric multicomponent addition of boronates to in 
situ generated ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-20% ethyl acetate in hexanes. Yield: 73% 
Enantiomeric Ratio: 94:6 [α]D (c 1.0M, CHCl3): +8.1° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 47.6 min., tr 
minor: 52.9 min.1H NMR (500 MHz, CDCl3): δ 7.55 (d, J = 8.3 Hz, 2H), 7.46 (d, J = 8.2 
Hz, 2H), 7.38 – 7.32 (m, 2H), 7.31 – 7.24 (m, 3H), 6.74 (dd, J = 15.9, 7.0 Hz, 1H), 6.61 
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(s, 1H), 6.43 (s, 1H), 6.39 – 6.34 (m, 1H), 5.90 (dd, J = 6.6, 1.4 Hz, 2H), 5.11 (d, J = 6.9 
Hz, 1H), 4.71 (s, 1H). 13C NMR (126 MHz, CDCl3): δ 147.82, 146.79, 141.79, 141.75, 
134.08, 130.44, 128.81, 128.52, 128.51, 127.00, 126.49, 125.49, 125.46, 121.18, 108.91, 
108.13, 106.64, 101.16, 101.15, 99.05, 98.29, 77.28, 77.03, 76.77, 47.83. IR (thin film, 
cm-1): 3853.2, 3747.6, 3445.2, 1699.1, 1651.4, 1558.3, 1540.3, 1487.3, 1436.1, 1325.8, 
1164.4, 1121.3, 1067.1, 1038.3, 667.7 MS (m/z): calculated for [C23H17F3O3H+]: 
399.1 m/z; found 399.0 m/z  
 
(S)-6-(furan-2-yl(phenyl)methyl)benzo[d][1,3]dioxol-5-ol (2.114o): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-15% ethyl acetate in hexanes. Yield: 100% 
Enantiomeric Ratio: 77:23 [α]D (c 1.0M, CHCl3):  +35.8° HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 30.1 min., tr 
minor: 34.7 min. 1H NMR (500 MHz, CDCl3): δ 7.40 (dd, J = 1.9, 0.9 Hz, 1H), 7.36 – 
7.29 (m, 2H), 7.29 – 7.23 (m, 1H), 7.22 – 7.16 (m, 2H), 6.43 (s, 1H), 6.40 (s, 1H), 6.32 
(dd, J = 3.2, 1.8 Hz, 1H), 5.96 (dt, J = 3.2, 0.9 Hz, 1H), 5.88 (q, J = 1.4 Hz, 1H), 5.63 (s, 
1H), 4.66 (d, J = 6.0 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 155.75, 147.83, 146.90, 
142.24, 141.67, 140.62, 128.64, 128.63, 128.54, 127.04, 120.30, 110.20, 109.16, 108.47, 
101.12, 98.95, 77.28, 77.02, 76.77, 44.71. IR (thin film, cm-1): 1734.9, 1699.8, 1651.4, 
1558.3, 1540.9, 1506.3, 1457.58, 1420.0 MS (m/z): calculated for [C18H14O4H+]: 295.1 
m/z; found 294.3 m/z. 
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(S,E)-6-(1-phenylhept-2-en-1-yl)benzo[d][1,3]dioxol-5-ol (2.114p): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-10% ethyl acetate in hexanes. Yield: 88% 
Enantiomeric Ratio: 95:5 [α]D (c 1.0M, CHCl3): +30.7° HPLC Analysis: Chiralcel OD 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 8.4 min., tr 
minor: 9.2 min.1H NMR (500 MHz, CDCl3): δ 7.32 (dd, J = 8.3, 6.9 Hz, 1H), 7.27 – 
7.17 (m, 3H), 6.49 (s, 1H), 6.43 (s, 1H), 5.93 – 5.80 (overlap, 3H), 5.49 (dtd, J = 15.1, 
6.9, 1.4 Hz, 1H), 4.80 (s, 1H), 4.77 (d, J = 6.9 Hz, 1H), 2.14-2.06 (m, 2H), 1.44-1.44 (m, 
4H), 0.90 (t, J = 7.1 Hz, 1H). 13C NMR (126 MHz, CDCl3): δ 148.21, 146.60, 142.29, 
141.50, 133.61, 130.79, 128.65, 128.49, 128.48, 126.70, 121.73, 108.82, 100.99, 99.03, 
77.26, 77.01, 76.76, 48.28, 32.19, 31.45, 22.28, 13.91. IR (thin film, cm-1): 3492.4, 
3059.1, 3025.4, 2956.2, 2925.7, 2361.4, 2337.9, 1619.0, 1579.1, 1501.8, 1483.7, 1435.6, 
1379.2, 1360.2, 1265.2, 1166.7, 1077.9, 1038.4, 1006.9, 975.9, 934.8, 881.7, 791.2, 
748.6, 700.9, 609.7  MS (m/z): calculated for [C20H22O3H+]: 311.2 m/z; found 311.1 
m/z. 
 
(S,E)-2-(1,3-diphenylallyl)-5-methoxyphenol (2.114q): The general procedure for the 
asymmetric multicomponent addition of boronates to in situ generated ortho-quinone 
methides.  The crude mixture was purified by flash column chromatography with elution 
from 5-10% ethyl acetate in hexanes. Yield: 71% Enantiomeric Ratio: 91:9 [α]D (c 1.0M, 
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CHCl3): +19.5° HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., Hexanes:IPA 
= 95:05, 1.0mL/min. tr major: 50.4 min., tr minor: 61.7 min. 1H NMR (500 MHz, 
CDCl3):  δ 7.19-7.44 (m, 10H), 7.03 (d, J = 8.5 Hz, 1H), 6.69 (dd, J = 15.9, 7.1 Hz, 1H), 
6.51 (dd, J = 8.5, 2.6 Hz, 1H), 6.43 (d, J = 2.5 Hz, 1H), 6.37 (d, J = 16.0 Hz, 1H), 6.06 (d, 
J = 7.1 Hz, 1H), 4.92 (s, 1H), 3.78 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 159.67, 
154.40, 142.16, 137.03, 131.71, 131.39, 130.33, 128.73, 128.59, 128.55, 127.47, 126.83, 
126.39, 121.62, 106.36, 102.51, 77.29, 77.04, 76.78, 55.33, 48.04. IR (thin film, cm-1): 
1734.7, 1699.1, 1652.09, 1616.99, 1558.5, 1540.4, 1508.2, 1456.9, 1161.2. MS (m/z): 
calculated for [C22H20O2H+]: 317.2 m/z; found 317.1 m/z. 
 
(S,E)-2-(1,3-diphenylallyl)-4,5-dimethoxyphenol (2.114r): The general procedure for the 
asymmetric multicomponent addition of boronates to in situ generated ortho-quinone 
methides.  The crude mixture was purified by flash column chromatography with elution 
from 5-20% ethyl acetate in hexanes. Yield: 73% Enantiomeric Ratio: 96:4 [α]D (c 1.0M, 
CHCl3): +9.1° HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., Hexanes:IPA 
= 95:05, 1.0mL/min. tr major: 30.4 min., tr minor: 36.0 min. 1H NMR (500 MHz, 
CDCl3): δ 7.41-7.20 (m, 9H), 6.68 (dd, J = 16.0, 7.0 Hz, 1H), 6.63 (s, 1H), 6.48 (s, 1H), 
6.38 (d, J = 16.0 Hz, 1H), 5.03 (d, J = 6.9 Hz, 1H), 4.67 (s, 1H), 3.83 (s, 3H), 3.75 (s, 
3H). 13C NMR (126 MHz, CDCl3): δ 148.76, 147.60, 143.16, 141.90, 136.90, 131.95, 
131.01, 128.78, 128.56, 128.52, 127.54, 126.93, 126.39, 120.00, 113.50, 101.75, 77.27, 
77.02, 76.76, 56.68, 55.94, 48.46, 31.58, 22.65, 14.12. IR (thin film, cm-1): 2361.6, 
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2337.4, 1734.7, 1716.7, 1684.5, 1651.9, 1558.3, 1540.4, 1508.8, 1457.1, 1200.6, 772.0. 
MS (m/z): calculated for [C23H22O3H+]: 347.2 m/z; found 347.3  
 
(S,E)-2-(1,3-diphenylallyl)-3,5-dimethoxyphenol (2.114t): The general procedure for the 
asymmetric multicomponent addition of boronates to in situ generated ortho-quinone 
methides.  The crude mixture was purified by flash column chromatography with elution 
from 0-15% ethyl acetate in hexanes. Yield: 30% Enantiomeric Ratio: 50:50. Spectral 
data is consistent with reported literature.127 
 
(S,E)-5-methoxy-2-(1-phenylhept-2-en-1-yl)phenol (2.114u): The general procedure for 
the asymmetric multicomponent addition of boronates to in situ generated ortho-quinone 
methides.  The crude mixture was purified by flash column chromatography with elution 
from 0-10% ethyl acetate in hexanes. Yield: 93% Enantiomeric Ratio: 96:4 [α]D (c 1.0M, 
CHCl3): +26.3° HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., Hexanes:IPA 
= 95:05, 1.0mL/min. tr major: 14.7 min., tr minor: 16.8 min. 1H NMR (500 MHz, 
CDCl3): δ 7.36 – 7.29 (m, 2H), 7.27 – 7.19 (m, 3H), 6.90 (dd, J = 8.5, 1.0 Hz, 1H), 6.46 
(ddd, J = 8.4, 2.6, 1.1 Hz, 1H), 6.43 (d, J = 2.5 Hz, 1H), 5.95 – 5.88 (m, 1H), 5.49 (dddd, 
J = 16.6, 8.0, 6.2, 1.2 Hz, 1H), 5.03 (s, 1H), 4.78 (d, J = 6.9 Hz, 1H), 3.77 (s, 3H), 2.14 – 
2.07 (m, 2H), 1.43-1.23 (m, 4H), 0.90 (t, J = 6.9 Hz, 1H). 13C NMR (126 MHz, CDCl3): 
δ 159.60, 154.64, 142.45, 133.48, 131.09, 130.14, 128.60, 128.59, 128.48, 126.61, 
121.79, 106.29, 102.41, 77.25, 77.20, 77.00, 76.74, 55.26, 48.26, 32.19, 31.46, 22.26, 
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13.90. IR (thin film, cm-1): 2925.1, 2360.8, 1617.1, 1558.6, 1506.5, 1456.3, 1145.0, 
772.6. MS (m/z): calculated for [C20H24O2H+]: 297.2 m/z; found 297.2 m/z. 
 
(R,E)-2-(1-(2-bromophenyl)-3-phenylallyl)-5-methoxyphenol (2.114v): The general 
procedure for the asymmetric multicomponent addition of boronates to in situ generated 
ortho-quinone methides.  The crude mixture was purified by flash column 
chromatography with elution from 0-10% ethyl acetate in hexanes. Yield: 70% 
Enantiomeric Ratio: 7:93 [α]D (c 1.0M, CHCl3): +5.5° HPLC Analysis: Chiralcel OD 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 20.3 min., tr 
minor: 13.5 min.1H NMR (500 MHz, CDCl3): δ 7.60 (dd, J = 8.0, 1.3 Hz, 1H), 7.37 (dd, 
J = 8.3, 1.4 Hz, 2H), 7.34 – 7.19 (m, 5H), 7.13 (ddd, J = 8.0, 7.2, 1.8 Hz, 1H), 6.92 (d, J = 
8.5 Hz, 1H), 6.58 (dd, J = 16.0, 6.3 Hz, 1H), 6.47 (dd, J = 8.5, 2.5 Hz, 1H), 6.43 (d, J = 
2.5 Hz, 1H), 6.24 (dd, J = 16.0, 1.6 Hz, 1H), 5.44 (dd, J = 6.3, 1.6 Hz, 1H), 4.92 (s, 1H), 
3.78 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 159.70, 154.49, 141.51, 136.95, 133.19, 
132.15, 130.31, 130.12, 128.55, 128.32, 127.55, 127.54, 126.42, 125.20, 120.43, 106.20, 
102.32, 77.30, 77.04, 76.79, 55.31, 46.68. IR (thin film, cm-1): 3853.5, 3747.7, 3673.8, 
3649.4, 3629.1, 2361.6, 2337.4, 1844.2, 1771.5, 1734.7, 1716.8, 1699.3, 1684.6, 1652.0, 
1635.5, 1617.1, 1558.5, 1540.5, 1519.5, 1507.8, 1457.9, 1435.8, 1291.0, 1203.5. MS 
(m/z): calculated for [C23H20O4H+]: 361.1 m/z; found 361.7 m/z.  
 
(S,E)-4-bromo-2-(1,3-diphenylallyl)-5-methoxyphenol (2.114w): The general procedure 
for the asymmetric multicomponent addition of boronates to in situ generated ortho-
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quinone methides.  The crude mixture was purified by flash column chromatography with 
elution from 5-15% ethyl acetate in hexanes. Yield: 49% Enantiomeric Ratio: 85:15 [α]D 
(c 1.0M, CHCl3): +7.9° HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., 
Hexanes:IPA = 95:05, 1.0mL/min. tr major: 19.7 min., tr minor: 19.0 min. 1H NMR (500 
MHz, CDCl3): δ 7.20-7.46 (m, 11H),  6.64 (dd, J = 16.6, 7.7 Hz, 1H), 6.46 (s, 1H), 6.37 
(d, J = 16.0 Hz), 5.11 (s, 1H), 5.00 (d, J = 7.1 Hz, 1H), 3.83 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 155.50, 153.88, 141.40, 136.74, 133.37, 132.20, 130.50, 
128.89, 128.57, 128.49, 127.64, 127.10, 126.43, 122.83, 102.17, 101.46, 77.27, 77.02, 
76.77, 56.30, 47.98. IR (thin film, cm-1): 1716.5, 1699.4, 1684.2, 1635.5, 1558.2, 1540.5, 
1530.7, 1507.2, 1457.3 MS (m/z): calculated for [C22H19BrO2H+]: 395.1, 397.1 m/z; 
found 395.1, 397.1 m/z. 
 
(6R,8S)-6-(4-methoxyphenyl)-8-phenyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene 
(2.115a): The general procedure for the asymmetric multicomponent cyclization of 
electron rich paramethoxy styrenyl boronate was used.  The crude mixture was purified 
by flash column chromatography with elution from 0-7.5% ethyl acetate in hexanes on 
neutral alumina.Yield: 40% Enantiomeric Ratio: 99:1 (major enantiomer) Diastereomeric 
Ratio: >20:1 [α]D (c 1.0M, CHCl3): -5.1° HPLC Analysis: Chiralcel OD column, 
24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 15.5 min., tr minor: 17.1 
min. 1H NMR (500 MHz, CDCl3): δ 7.14-7.41 (m, 7H), 6.90-6.94 (m, 2H), 6.48 (s, 1H), 
6.21 (s, 1H), 5.84 (dd, J = 8.3, 1.4 Hz, 2H), 5.07 (dd, J = 11.5, 1.8 Hz, 1H), 4.25 (dd, J = 
12.0, 6.1 Hz, 1H), 3.82 (s, 3H), 2.12-2.50 (m, 2H). 13C NMR (126 MHz, CDCl3): δ 
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159.43, 150.48, 147.13, 146.66, 146.28, 144.84, 141.62, 141.53, 133.32, 133.19, 128.66, 
128.61, 128.50, 128.42, 128.40, 127.50, 127.41, 127.38, 126.75, 126.39, 117.26, 114.35, 
113.97, 113.93, 113.82, 109.02, 108.41, 100.90, 100.85, 98.60, 98.54, 77.87, 77.27, 
77.01, 76.76, 72.78, 55.32, 55.29, 43.58, 40.51, 40.44, 38.07. IR (thin film, cm-1): 
2914.5, 2361.6, 2337.3, 1734.7, 1558.40, 1509.1, 1479.0, 1457.1, 1248.5, 1178.3, 1148.6, 
1090.8, 1037.0.  
MS (m/z): calculated for [C23H20O4H+]: 361.1 m/z; found 361.7 m/z.  
 
(6R,8S)-6-(4-methoxyphenyl)-8-(4-(trifluoromethyl)phenyl)-7,8-dihydro-6H-
[1,3]dioxolo[4,5-g]chromene (2.115b): The general procedure for the asymmetric 
multicomponent cyclization of electron rich paramethoxy styrenyl boronate was used.  
The crude mixture was purified by flash column chromatography with elution from 0-
7.5% ethyl acetate in hexanes on neutral alumina. Yield: 42% Enantiomeric Ratio: 98:2 
(major enantiomer) Diastereomeric Ratio: 6.0:1 [α]D (c 1.0M, CHCl3): -14.6° HPLC 
Analysis: Chiralcel OD column, 24cm×4.6 mm I.D., Hexanes:IPA = 99:01, 1.0mL/min. 
tr major: 18.3 min., tr minor: 13.1 min. 1H NMR (500 MHz, CDCl3): δ 7.58 (d, J = 8.1 
Hz, 2H), 7.22-7.41 (m, 4H), 6.90-6.95 (m, 2H), 6.49 (s, 1H), 6.14 (s, 1H), 5.86 (dd, J = 
7.3, 1.4 Hz, 2H), 5.06 (d, J = 10.0 Hz, 1H), 4.34 (dd, J = 12.0, 6.2 Hz, 1H), 3.81 (s, 3H), 
2.30-2.40 (m, 1H), 2.11-2.22 (m, 1H). 13C NMR (126 MHz, CDCl3): δ 159.54, 159.35, 
150.63, 150.35, 149.15, 147.49, 147.01, 141.74, 132.93, 132.85, 129.22, 128.97, 128.95, 
128.75, 127.45, 127.35, 125.69, 125.66, 125.63, 125.60, 125.42, 125.39, 116.08, 113.98, 
113.90, 113.29, 108.72, 108.09, 101.02, 100.97, 98.82, 98.75, 77.66, 77.27, 77.01, 76.76, 
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72.69, 55.31, 55.28, 43.43, 40.48, 40.37, 37.86. IR (thin film, cm-1): 1616.3, 1515.0, 
1481.2, 1438.1, 1326.1, 1249.1, 1150.2, 1123.4, 1067.9, 1038.5, 939.9, 833.9. MS (m/z): 
calculated for [C24H19F3OH+]: 429.1 m/z; found 429.5 m/z. 
 
(6R,8S)-6,8-bis(4-methoxyphenyl)-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene 
(2.115c): The general procedure for the asymmetric multicomponent cyclization of 
electron rich paramethoxy styrenyl boronate was used.  The crude mixture was purified 
by flash column chromatography with elution from 0-7.5% ethyl acetate in hexanes on 
neutral alumina.Yield: 27% Enantiomeric Ratio: 99:1 (major enantiomer)Diastereomeric 
Ratio: 5.7:1[α]D (c 1.0M, CHCl3): -14.3° HPLC Analysis: Chiralcel OD column, 
24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 1.0mL/min. tr major: 13.8 min., tr minor: 19.2 
min. 1H NMR (500 MHz, CDCl3): δ 7.39 (d, J = 8.4 Hz, 2H), 7.13 (d, J = 8.4 Hz, 2H), 
6.95-6.84 (m, 4H), 6.47 (s, 1H), 6.23 (s, 1H), 5.84 (d, J = 8.1 Hz, 2H), 5.07 (d, J = 10.9 
Hz, 1H), 4.20 (dd, J = 12.0, 6.0 Hz, 1H), 3.78-3.84 (m, 6H), 2.07-2.45 (m, 2H). 13C 
NMR (126 MHz, CDCl3): δ 159.42, 159.22, 158.40, 158.12, 150.39, 150.21, 147.07, 
146.62, 141.60, 141.51, 138.45, 136.81, 133.43, 133.28, 129.52, 129.35, 127.48, 127.40, 
117.66, 114.76, 114.06, 113.95, 113.93, 113.83, 113.77, 109.01, 108.37, 100.87, 100.84, 
100.82, 98.55, 98.51, 77.94, 77.28, 77.03, 76.77, 72.81, 55.31, 55.28, 55.27, 42.75, 40.57, 
39.62, 38.30.IR (thin film, cm-1): 1612.9, 1511.5, 1477.8, 1248.0, 1176.7, 1147.9, 
1036.0.MS (m/z): calculated for [C24H22O5H+]: 391.1 m/z; found 391.2 m/z. 
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8-(2-bromophenyl)-6-(4-methoxyphenyl)-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene 
(2.115d): The general procedure for the asymmetric multicomponent cyclization of 
electron rich paramethoxy styrenyl boronate was used.  The crude mixture was purified 
by flash column chromatography with elution from 0-7.5% ethyl acetate in hexanes on 
neutral alumina. Yield: 33% Enantiomeric Ratio: 98.5:1.5 (major enantiomer) 
Diastereomeric Ratio: 1.5:1 [α]D (c 1.0M, CHCl3): +2.1°  HPLC Analysis: Chiralpak IA 
column, 24cm×4.6 mm I.D., Hexanes:IPA = 99:01, 1.0mL/min. tr major: 27.0 min., tr 
minor: 25.8 min. 1H NMR (500 MHz, CDCl3): δ 7.55-7.63 (m, 1H), 7.39 (d, J = 8.7 Hz, 
2H), 7.20-7.29 (m, 2H), 7.05-7.14 (m, 1H), 6.92 (d, J = 8.7 Hz, 2H), 6.50 (s, 1H), 6.21 (s, 
1H), 5.86 (dd, J = 12.8, 1.4 Hz, 2H), 5.07 (d, J = 11.2 Hz, 1H), 4.83-4.92 (overlap, 1H), 
3.82 (s, 3H), 1.95-2.55 (m, 2H). 13C NMR (126 MHz, CDCl3): δ 159.48, 159.34, 
150.72, 147.36, 146.79, 144.79, 141.87, 141.73, 133.03, 133.00, 131.44, 129.50, 128.18, 
128.08, 128.00, 127.58, 127.54, 127.20, 124.10, 113.94, 113.86, 113.66, 108.86, 108.14, 
100.97, 100.92, 98.86, 98.58, 77.78, 77.27, 77.01, 76.76, 72.73, 55.33, 55.30, 41.94, 
40.33, 38.79, 35.58. IR (thin film, cm-1): 1614.2, 1514.4, 1478.8, 1248.1, 1179.4, 1150.3, 
1037.6, 940.2, 833.0, 755.7. MS (m/z): calculated for [C23H19BrO4H+]: 439.1, 441.1 
m/z; found 439.0, 441.0  m/z. 
 
(R)-6-(4-methoxyphenyl)-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene (2.115e): The 
general procedure for the asymmetric multicomponent cyclization of electron rich 
paramethoxy styrenyl boronate was used.  However, 5 equiv. of aldehyde were used 
instead.  The crude mixture was purified by flash column chromatography with elution 
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from 0-7.5% ethyl acetate in hexanes on neutral alumina.  Spectral data in agreement 
with literature.128 Yield: 51% Enantiomeric Ratio: 61:39 [α]D (c 1.0M, CHCl3): -1.3° 
HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm I.D., Hexanes:IPA = 98:02, 
1.0mL/min. tr major: 15.9 min., tr minor: 13.9 min. 1H NMR (500 MHz, CDCl3): δ 7.35 
(d, J = 8.5 Hz, 2H), 6.93 (d, J = 8.5 Hz, 2H), 6.54 (s, 1H), 6.46 (s, 1H), 5.87-5.88 (m, 
2H), 4.93 (dd, 2.5 Hz, 10.5 Hz, 1H), 3.82 (s, 3H), 2.94-2.87 (m, 1H), 2.67-2.72 (m, 1H), 
2.02-2.17 (m, 2H).13C NMR (126 MHz, CDCl3): δ 159.28, 146.37, 141.34, 133.77, 
129.52, 127.34, 114.02, 113.88, 113.15, 108.12, 100.75, 98.76, 77.43, 55.30, 55.27, 
29.74, 25.25. IR (thin film, cm-1): 1249.3, 1150.7, 1036.3. MS (m/z): calculated for 
[C17H16O4H+]: 285.1 m/z; found 285.3 m/z. 
 
(R)-6-(4-methoxyphenyl)-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromene (2.115f): The 
general procedure for the asymmetric multicomponent cyclization of electron rich 
paramethoxy styrenyl boronate was used.  However, cyclization at 150C was run for 24 
hours.  The crude mixture was purified by flash column chromatography with elution 
from 0-5% ethyl acetate in hexanes on neutral alumina. Yield: 32% Enantiomeric Ratio: 
85:15 [α]D (c 1.0M, CHCl3): -5.1° HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm 
I.D., Hexanes:IPA = 98:02, 1.0mL/min. tr major: 12.7 min., tr minor: 12.2 min. 1H NMR 
(500 MHz, CDCl3): δ 7.50-7.45 (m, 2H), 7.43-7.37 (m, 2H), 7.36-7.30 (m, 3H), 7.28-
7.20 (m, 3H), 5.85 (dd, J = 8.4, 1.3 Hz, 2H), 5.13 (d, J = 11.7 Hz, 1H), 4.27 (dd, 11.7, 6.1 
Hz, 1H), 2.40 (ddd, J = 13.8, 6.1, 1.9 Hz, 1H), 2.27-2.16 (m, 1H). 13C NMR (126 MHz, 
CDCl3): δ 150.34, 146.72, 144.74, 141.60, 141.08, 128.68, 128.54, 128.43, 128.05, 
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126.78, 126.07, 117.30, 108.41, 100.88, 98.62, 78.17, 77.28, 77.03, 76.77, 43.52, 40.76, 
29.72. IR (thin film, cm-1): 1498.3, 1453.8, 1434.5, 1246.4, 1183.1, 1146.9, 1091.6, 
1040.5. MS (m/z): calculated for [C23H18O3H+]: 331.1 m/z; found 331.1 m/z. 
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Selected example of HPLC trace (2.115a): 
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CHAPTER 3 
 
 
 
 
An Enantioselective Multicomponent Cycloaddition Reaction of ortho-
Quinone Methide Intermediates and its Application to Myristinins A-C 
 
 
 
 
Introduction 
 
 Transformations utilizing ortho-quinone methide intermediates have become 
more popular over recent years. New methods to generate and control this reactive 
intermediate have led to powerful bond connections.129 Significant attention has been 
placed on asymmetric transformations of in situ generated ortho-quinone methides from 
bench stable precursor starting materials. Recently, chiral Bronsted acids paired with 
hydroxybenzyl alcohols have become popular due to the mild conditions needed for 
ortho-quinone methide generation.8,45 This approach has enabled a broad substrate scope 
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when compared to earlier transformations of bench stable ortho-quinone methides, which 
required linear conjugation and electron rich substitution to enhance stability.  
As observed in the previous chapter, the Friedel-Crafts hydroxy-alkylation 
reaction is a powerful platform to access ortho-quinone methides from commercially 
available starting materials. This method employed boronate nucleophiles in combination 
with catalytic quantities of chiral BINOL derivatives to provide di- and triaryl methane 
products with high levels of enantioselectivity. During this reaction sequence, we 
observed a cyclization event, which ultimately led to 2,4-disubstituted chroman products, 
a scaffold commonly found in natural products and drugs. For instance, myristinins A-C 
3.1 are potent inhibitors of DNA polymerase β and contain the 2,4-diaryl chroman motif 
within their framework (Figure 3.1).  
 
Figure 3.1 Myristinins A-C natural products. 
 
 
We set out to synthesize the core of the Myristinin family of natural products A-C 
to demonstrate the effectiveness of this new multicomponent organoboron reaction. 
Initial efforts were put forth to utilize the cyclization strategy, which ultimately met 
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failure. The scope of this cyclization is limited to the use of electron-rich styrenyl 
boronates. Additionally, high temperatures encouraged the racemization of stereocenters, 
requiring recrystallization to access products with high levels of enantio- and 
diastereoselectivity. Cycloadditions of ortho-quinone methides are well known in the 
literature and recent methods have been carried out using typical in situ generation from 
stable precursors. We postulated that the multicomponent organoboron platform would 
be a viable method to access these chiral products with improved efficiency and 
practicality.  
 
 
Figure 3.2 Enantioselective multicomponent cycloaddition strategy to access 
chroman products involving an ortho-quinone methide intermediate.  
 
In an effort to access the myristinin scaffold and expand the scope of the 
cyclization process, we developed an asymmetric, multicomponent cycloaddition from 
readily available starting materials (Figure 3.2, Eq. 1). The method was then employed to 
access the core structure of the myristinin family of natural products.  	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Background 
 
Ortho-Quinone Methide Reactivity in Diels Alder Reactions 
 
 Apart from nucleophilic additions to ortho-quinone methides to generate ortho-
branched alkyl-substituted phenols, the inverse electron demand Diels-Alder reaction 
with olefins is the other most exploited reaction pathway of this intermediate. In fact, 
initial investigations to validate their existence came about from the formation of dimer 
and trimer cycloaddition products via oxidation chemistry.46,51–53 Although previous 
attempts to observe the functionality by way of spectroscopy had failed, based on these 
observations, Bolon postulated that this intermediate should have an appreciable lifetime 
in solution. To test his hypothesis, he introduced dienophiles into the reaction mixture to 
compete with the dimerization process and obtained chromans products 3.8 from 4-ter-
butyl-2,6-xylenol 3.6 starting material (Figure 3.3, Eq. 2).  
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Figure 3.3 Formation of ortho-quinone methide intermediates via oxidation and 
subsequent participation in cycloadditions. 
 
 Electron rich olefins ethyl vinyl ether and styrene were effective dienophiles, 
affording 3.8a and 3.8c in 80% and 40% yields, respectively.  Products 3.8b and 3.8d 
were obtained in less than 30% yield. Electron-rich dienophiles provided higher yields, 
suggesting an inverse electron demand Diels-Alder mechanism. It is crucial to use a high 
concentration of dienophile to prevent the dimer- and trimerization adducts of starting 
material, since there is an inherent competition of rates in intermolecular cycloaddition 
reactions with ortho-quinone methides. However, intramolecular cycloadditions of ortho-
quinone methides have circumvented this issue with much success.  An example from 
Casiraghi accessed the hexhydrocannabinol scaffold through a Friedel-Crafts hydroxy-
alkylation.131  
 
 
Figure 3.4 Intramolecular cycloadditions out compete rate of ortho-quinone methide 
dimerization. 
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 This hexahydrocannabinol scaffold has been accessed from similar chemistries in 
various groups (Figure 3.4, Eq. 3).27 The ortho-selective condensation between 3.9 and 
(S)-3.10 utilized diethylaluminum chloride Lewis acid.  The in situ generated ortho-
quinone methide 3.11 preferentially cyclizes with the tethered olefin to give the 
hexahydrocannabinol core 3.12.  As a consequence of the intramolecular nature of this 
reactivity, the resultant compound is a single enantiomer when enantiopure starting 
material is used. 
 
 
Figure 3.5 X-ray crystallography of a stabilized ortho-quinone methide. 
 
 The establishment of a the bench stable ortho-quinone methide by Jurd allowed 
Domiano to confirm their preference for E-olefin geometry using X-ray 
crystallography.132 At room temperature, the ortho-quinone methide was reacted with 
ethyl vinyl ether to furnish chroman product 3.16 as a single diastereomer, which 
provided evidence that ortho-quinone methides prefer to react with vinyl ethers in an 
endo transition state (Figure 3.5, Eq. 4). Based upon experimentally observed 
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stereochemical outcomes, the cycloadditions of ortho-quinone methides tend to provide 
cis products under kinetic conditions, whereas thermal conditions favor a trans 
geometry.27  
 
Ortho-Quinone Methide Cycloadditions in Synthesis 
 
 Cycloaddition reactions of ortho-quinone methides occur under the same reaction 
conditions as nucleophilic additions, since the difficulty of the transformation is the 
controlled generation of the transient intermediate. Thus, methods to generate ortho-
quinone methides for use in cycloadditions typically the same as those for nucleophilic 
additions, often using oxidation, thermolysis, or acid/base chemistry; high concentrations 
of dienophile are used to prevent the self-destruction of the transient intermediate.  
Chemistries exploiting cycloadditions with ortho-quinone methides are complementary to 
those of nucleophilic additions since many research groups have featured both in their 
work. Of the most valuable methods for synthesis, the in situ formation of ortho-quinone 
methides was highly developed for the synthesis of chromans.129  
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Figure 3.6 Biomimetic synthesis of lucidene through ortho-quinone methide 
intermediate. 
 
Lucidene 3.19 is a sesquiterpene from the root bark of Uvaria Lucida co-isolated 
with α-humulene 3.17. Speculation of a biosynthetic pathway proceeding through a 
hetero Diels-Alder preempted Baldwin to conduct studies towards its synthesis.133 
Generation of the ortho-quinone methide intermediate comes from hydroxybenzyl 
alcohol precursor 3.18, which is activated through thermal extrusion of water to form 
lucidene in 32% yield (Figure 3.6, Eq. 5). 
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Figure 3.7 Biomimetic synthesis of sideroxylonal B through ortho-quinone methide 
intermediate. 
 
A benzyl alcohol was used as the ortho-quinone methide precursor in the 
biomimetic synthesis of Sideroxylonal B by Tatsuta.72 Trifluoroborate diethyl etherate 
promoted Friedel-Crafts hydroxy-alkylation reaction of 3,5-dimethoxy phenol 3.20 with 
isovaleric acid 3.21, followed by reduction using lithium aluminum hydride installed the 
benzyl alcohol 3.22 in 82% yield (Figure 3.7, Eq. 6). This key ortho-quinone methide 
precursor was activated using ethyl magnesium bromide to form both the ortho-quinone 
methide 3.23 and its cycloaddition partner 3.24 simultaneously in one pot. Heating the 
mixture in refluxing benzene provided a respectable 78% yield of 3.25a, an epimer of the 
natural product core. Under forcing thermal conditions, they found that equilibration to 
the correct epimer provided 3.25b in a 74% yield. Finally, a series of transformations and 
global deprotection provided Sideroxylonal B. 
In 2011, Luan and Schaus discovered that FeCl3•6H2O served to catalyze the 
homodimerization of 2H-chromenes affording tetrahydrochromeno polycyclic cores, 
which are found in natural products such as mulberrofuran G, australisine A, and 
sorocenol E.  Reactions were initiated by an FeCl3•6H2O catalyzed oxa-6π rearrangement 
to form the reactive ortho-quinone methide intermediate 3.28 in situ, which underwent a 
homodimerization to give product 3.29 in good yields (Figure 3.8, Eq. 7). In the course of 
their studies, they found electron-rich chromene reaction partners underwent an 
FeCl3•6H2O mediated hydride-shift, which provided chromene isomer 3.30. The oxygen-
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substituted olefin was found to be an extremely competent dienophile and provided 3.31 
exclusively (Figure 3.8, Eq. 8). Styrene 3.30 also afforded the cycloaddition product as a 
single diastereomer, which is due to the endo selectivity in the cycloaddition as a 
consequence of its electron-rich functionality. The mechanism was investigated using 
deuterium labeling of the 2H-chromene and confirmed the proposed hydride shift. Steps 
were taken to react 2H-chromene 3.27a with dienophiles (Figure 3.8, Eq. 9). Electron 
rich styrenes were selected for their ability to outcompete the dimerization process, but 
required 2-20 equivalents for good yields.  In one example, 2H-chromene 3.27a and 5.0 
equivalents of cyclic styrene 3.32 in the presence of 40 mol % catalyst provided chroman 
product 3.33 in 82% yield as a single diastereomer. 
In the same publication, Schaus and Luan were able to apply this methodology to 
the synthesis of (±)-dependensin. Chromene starting material 3.34 was prepared in three 
steps and subjected to catalytic FeCl3•6H2O to provide (±)-dependensin 3.35 in 62% 
yield as a single diastereomer (Figure 3.9, Eq. 10). A similar synthesis of (±)-
dependensin was done by Deodhar in 2007 using Bronsted acid catalysis but lacked 
stereocontrol and step-economy.134 
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Figure 3.8 Generation of ortho-quinone methide intermediate via oxa-6π 
rearrangement of 2H-chromenes. 
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Figure 3.9 Synthesis of (±)-dependensin via ortho-quinone methide intermediate. 
 
The Trauner group has been a large contributer to ortho-quinone methide based 
transformations in synthesis.41,135,136 In a notable publication, the key transformation in 
his biomimetic synthesis of rubicordifolin exploits an ortho-quinone methide [4+2]-
cycloaddition between intermediate 3.36 and its isomer 3.37, which is easily accessed by 
spontaneous degredation (Figure 3.10, Eq. 11). Phenyl boronic acid in refluxing toluene 
facilitates demethylation of 3.36 and cyclization to form ortho-quinone methide 
intermediate 3.38 in situ.  Simultaneously, the acidic conditions dehydrate 3.37 providing 
3.39 as the dienophile for the cycloaddition reaction.  The bulky isopropoxy group of 
3.38 provides a steric bias and facial selectivity while 3.39 approaches endo to the ortho-
quinone methide to provide Rubicordifolin 3.40 in 45% overall yield. Since then, Trauner 
has provided the total syntheses of Variecolortides A and B, also through a key ortho-
quinone methide [4+2]-cycloaddition transformation.137 
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Figure 3.10 Biomimetic synthesis of Rubicordifolin via ortho-quinone methide.  
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It was Pettus who paved the way for asymmetric cycloadditions of ortho-quinone 
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tolterodine from a diastereoselective transformation.40 The power of this method should 
not be understated; it provides high stereocontrol of chroman products under mild 
conditions and boasts a one-pot protocol. Nonetheless, the method requires the use of a 
chiral auxiliary reagent to impart the stereoselectivity. 
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phosphoric acid catalysis, although exceptions occur. Under this set of conditions, 
nucleophilic additions to ortho-quinone methides are believed to proceed under a 
bifunctional mode of catalysis, whereby the phosphoric acid catalyst coordinates to both 
the nucleophile and the electrophile simultaneously in the transition state. A recent 
example from Schneider showed his interpretation of the enantiodetermining event where 
catalyst 3.42 directs nucleophile 3.44 to the ortho-quinone methide 3.43 intermediate 
(Figure 3.11, Eq. 12). 
 
 
Figure 3.11 Proposed bifunctional mode of catalysis stabilizing ortho-quinone 
methide intermediate. 
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explain why cycloadditions catalyzed by BINOL-derived phosphoric acids have yet to be 
observed in the literature.  
 
 
Figure 3.12 Stereoselective synthesis of chromans involving ortho-quinone methide 
intermediates.  
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concerted process seems unlikely for this particular transformation. The typical 
stereochemical outcome of an ortho-quinone methide cycloaddition is the result of an 
endo approach of the incoming dienophile in the transition state, which contradicts the 
observed stereochemical outcome of product 3.48 (Figure 3.12, Eq. 13). Secondly, a 
concerted cycloaddition process retains the stereochemistry from starting materials to 
product. Indole (Z)-3.46 of opposite olefin geometry was subjected the same reaction 
conditions and gave product 3.48 with the same absolute stereochemistry as before. Shi 
and coworkers rationalized that this result is likely due to isomerization of the double 
bond before the reaction takes place, although it appears to be the result of a step-wise 
pathway leading to product. Finally, in a previous publication from Shi, they suggested 
that the same indole (E)- 3.46 acts as a competent nucleophile at low temperatures in the 
formal [3+2]-cycloaddition of 3,3’-spirooxindoles catalyzed by chiral phosphoric acid 
catalyst 3.47 in transition state 3.51 (Figure 3.12, Eq. 14).139 Thus, at higher 
temperatures, additions of (E)- 3.46 to a transient intermediate such as an ortho-quinone 
methide should be an extremely facile process. 
 It was Rueping and coworkers who established the first precedence for 
organocatalytic, asymmetric [4+2]-cycloadditions of in situ generated ortho-quinone 
methides with alkenes. Previous computational work described by Freccero illustrates a 
stabilization of the reactive ortho-quinone methide carbon via hydrogen bonding with 
oxygen or nitrogen lone pairs.140,141 Additionally, a collaboration between Rueping and 
Leito, in which they experimentally determined pKa values for common chiral Bronsted 
acid catalysts, discovered that N-trifylphosphoramides typically have a pKa range of 6-7 
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whereas BINOL-derived phosphoric acids are typically around 12-14; they report that N-
trifylphosphoramides may perform better to activate benzyl alcohol precursors.142 
 
 
Figure 3.13 Asymmetric cycloadditions of unactivated alkenes through an ortho-
quinone methide intermediate.  
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Thus, BINOL-derived N-trifylphosphoramides were tested as catalyst to facilitate 
the desired reaction pathway.  Starting from benzyl alcohol 5.52 and styrene, conditions 
were found to produce chroman scaffolds with high levels of yield, enantio- and 
diastereoselectivity using only 5 mol % catalyst (R)-5.54 (Figure 3.13, Eq. 15). Suitable 
conditions were taken forward to explore the scope of the reaction. Catalyst (R)-5.54 
facilitated the cycloaddition of benzyl alcohol 5.52 and styrene 5.53 at -60 °C with 4Å 
molecular sieves in toluene giving products 5.55 in 45-95% yields with high levels of 
both enantio- and diastereoselectivity. A few examples were selected that highlight the 
reactivity. Electron donating groups were observed in each benzyl alcohol 5.52 scaffold, 
suggesting that the ortho-quinone methide is at least partially stabilized through 
resonance.28 No electron-neutral benzyl alcohols were mentioned in the manuscript. 
Nonetheless, styrene performed well in the reaction, especially with methyl substitution 
providing enhancement in stereoselectivities for products 5.53a-5.53d. Halogen 
substitution also worked well in the reaction providing 5.53e in 76% yield, 90% ee, and 
49:1 dr. Additional electron donating groups on benzyl alcohol 5.52 provided better 
stereoselectivity in product 5.53f, lending credence to the importance of ortho-quinone 
methide stability. Thus, BINOL-derived N-trifylphosphoramides were proven to be 
useful catalysts in the asymmetric cycloaddition reaction of in situ generated ortho-
quinone methides. 
 In our previous efforts, a multicomponent platform to access ortho-quinone 
methides in situ from the Friedel-Crafts hydroxy-alkylation condensation proved 
successful for the asymmetric addition of boronate nucleophiles catalyzed by chiral 
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biphenols. A surge of recent reports of organocatalytic, asymmetric nucleophilic 
additions to ortho-quinone methides has supported this synthetic need. Organocatalytic, 
asymmetric methods to access the chroman scaffold are lacking, with only two reports in 
the literature. Given the known reactivity of ortho-quinone methides, we decided to 
explore the use of our boron-mediated multicomponent approach to access chroman 
scaffolds in the synthesis of myristinins A-C. 	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Results and Discussion 
 
 Multicomponent Cyclization Efforts to Access Myristinins A-C 
 
 In our report of enantioselective multicomponent condensation reactions of 
phenols, aldehydes, and boronates catalyzed by chiral biphenols, we demonstrated a 
cyclization process to furnish 2,4-diaryl chroman products in moderate yields with useful 
levels of selectivity after product recrystallization.143 With these results in hand, we 
sought to demonstrate the utility of this method in a synthesis of myristinins A-C natural 
products.  
 
 
Figure 3.14 Envisioned route to myristinins A-C via multicomponent reaction 
involving ortho-quinone methide intermediate. 
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3.14, Eq. 16). Global deprotection144 of the peripheral methoxy groups would be 
accomplished using boron tribromide to furnish myristinins A-C. A model reaction was 
developed that employed trimethoxybenzaldehyde 3.59 in order to find suitable 
conditions for the transformation to occur (Figure 3.15, Eq. 17). 
 
 
Figure 3.15 Efforts towards the multicomponent cyclization to access myristinin 
core structure. 
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 The asymmetric boronate addition was carried out using our previously 
established conditions to gain an initial understanding of the reactivity between these 
components. Product formation occurred after 48 hours at 80 °C, giving 30% yield of 
3.61 with modest levels of enantioselectivity (Figure 3.15, Eq. 17). Previous reactions 
also gave modest levels of enantioselectivity for this particular electron-rich styrenyl 
boronate used, which is likely due to a background reaction rate. We hypothesized that 
the long reaction time and low yield observed is a result of the electron-rich nature of the 
aldehyde 3.59. Additionally, bis-ortho substitution renders the aldehyde sterically 
crowded, hindering the reactivity. The reaction was then tested at higher temperature to 
increase the reactivity, but a black film developed on the sides of the glassware. 
Polymerization and undesired side product formations were attributed to the observed 
outcome (Figure 3.15, Eq. 18). Catalyst (R)-3.62 was used with our previously optimized 
reaction conditions, 80 °C for 24 hours followed by 150 °C for a brief period of time, 
which yielded only addition product. Styrene 3.63 was observed by allowing the reaction 
to proceed at the increased temperature for 24 hours, which is possibly a degradation 
product of boronate 3.57.  
Chroman product formation is likely mediated by the chiral BINOL catalyst in a 
stepwise cyclization pathway, a conclusion supported by the results of our cyclization 
study because the enantiomeric ratio of the product is higher than that of the starting 
material. Therefore, it is possible that bis-ortho functionalization of compound 3.61 may 
hinder the chiral biphenol assisted cyclization. If the formation of cyclization product 
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3.64 does indeed occur under these highly thermal conditions, a retro-Diels-Alder event 
is a plausible pathway (Figure 1.16, Eq. 20). Rokita demonstrated that electron-rich 
substituents help to stabilize ortho-quinone methide intermediates, which increases its 
rate of re-forming in solution.67 This pathway cannot be ruled out, since styrene 3.63 was 
observed in the reaction under prolonged thermal conditions. Additionally, irreversible 
self-destructive pathways of ortho-quinone methides 3.65 can compete to shift product 
distributions away from cycloadduct 3.64.  
 
 
Figure 3.16 Proposed retro-cycloaddition of chroman.  
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and electron neutral boronates require harsh conditions over longer periods of time. 
Lastly, it was found that electron donating substituents help facilitate the reformation of 
the ortho-quinone methide intermediate in situ, which as a consequence, erodes the newly 
formed stereochemistry of the cycloadduct. Encouraged to construct the core of 
myristinins A-C in a multicomponent reaction, we decided to abandon the cyclization 
strategy and attempt a multicomponent assembly using our boron-mediated Friedel-
Crafts hydroxy-alkylation chemistry. 
 
Development of an Enantioselective Multicomponent Condensation Reaction of Phenols, 
Aldehydes, and Styrenes Catalyzed by Chiral Biphenols 
  
 Racemic multicomponent reactions of phenols, aldehydes, and styrenes catalyzed 
by Bronsted acids have been reported in the literature.108,109,145 We set out to develop an 
asymmetric, multicomponent cycloaddition reaction founded upon our previously 
established organoboron multicomponent reaction to access the core of the myristinin 
family of natural products. Borate ester Lewis acid was selected to promote a Friedel-
Crafts condensation process between an activated phenol and an aromatic aldehyde. In 
situ generation of an ortho-quinone methide intermediate could be trapped by an electron 
rich styrene to furnish the cycloaddition product. We envisioned a dual catalyst system, 
whereby a chiral biphenol catalyst could bind to the Lewis acid provide facial selectivity 
in the cycloaddition step.146 
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 Studies were initiated using sesamol 3.66, benzaldehyde 3.67, and 4-vinyl anisole 
3.68, 2.0 equivalents of boron Lewis acid and 15 mol % of 3,3’-(R)-I2BINOL catalyst 
3.69a in toluene at 80 °C for 24 hours (Table 3.1). We were pleased to find that borate 
Lewis acid was indeed capable of mediating a Friedel-Crafts hydroxy-alkylation in a 
multicomponent cycloaddition to furnish 2,4-diaryl chroman products 3.71 from 
commercially available starting materials. Boric acid provided product in 39% yield with 
little enantioselectivity (Table 3.1, Entry 1).  
 
Table 3.1 Lewis acid screen of the multicomponent cycloaddition. 
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Trimethyl borate was tested in the reaction conditions and furnished product in 
27% yield, but with moderate levels of enantioselectivity (Table 3.1, Entry 2). Borate 
ester Lewis acids are capable of rapid transesterification, which we attribute to a facile 
exchange process with the chiral biphenol catalyst.117 Triethyl borate and triisopropyl 
borate were also tested and gave similar selectivities with moderate yields (Table 3.1, 
Entries 3 and 4). Encouraged by these initial results, experiments were designed to 
evaluate a diverse collection of chiral diol catalysts in the multicomponent reaction using 
triisopropyl borate Lewis acid. 
Benzaldehyde dimethyl acetal 3.72 was found to increase the yield of product 
relative to aldehyde 3.66 and was carried forward in the catalyst screen (Figure 3.17, Eq. 
21). BINOL-derived catalysts containing substitution at the 3,3’-positions of the scaffold 
gave similar yields and selectivities 3.69a-3.69g. Hydrogenated BINOLs 3.69h and 3.69i 
were run in the reaction conditions producing low yields and nearly racemic results. We 
decided to diversify the scaffolds in the collection of diols since the substituted BINOL 
catalysts were not providing high enantioselectivities.  Tartaric acid based chiral diols 
3.69j and 3.69k gave higher yields and diastereomeric ratios, which may be attributed to 
the increased acidity; unfortunately, both results were racemic. Vaulted biaryl diols have 
provided highly enantioselective transformations in the literature and were also tested. 
VANOL catalyst 3.69l gave 48% yield, 81:19 er, and 4:1 dr, which proved to be superior 
to the BINOL scaffold. VAPOL catalyst 3.69m was then tested and provided 56% yield, 
88:12 er, and 5:1 dr. VAPOL catalyst 3.69m was selected as the catalyst of choice for 
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further optimizations due to its effective induction of asymmetry in the multicomponent 
reaction. 
 
 
O
O O
OCH3
O
O OH
OCH3
OCH3 30 mol % (R)-3.69
2.0 equiv. B(OiPr)3
80 °C PhCH3 24 h+
OCH3
3.66 3.72
3.68
3.71
OH
OH
I
I
OH
OH
Ph
Ph
30% yield
53:47 er
2:1 dr
OH
OH
26% yield
68:32 er
2:1 dr
HO
O
OH
OH
O
N Bn
Bn
50% yield
50:50 er
5.0:1 dr
HO
O
OH
OH
O
OH
62% yield
55:45 er
3.6:1 dr
OH
OH
Br
Br
25% yield
50:50 er
2:1 dr
OH
OH
TMS
TMS
OH
OH
O
O
O
O
OH
OH
F
F
32% yield
60:40 er
2:1 dr
OH
OH
CF3
CF3
37% yield
72:28 er
2:1 dr
OH
OH
Br
Br
38% yield
70:30 er
2:1 dr
OH
OHPh
Ph
56% yield 
88:12 er
5:1 dr
OH
OHPh
Ph
46% yield
77:23 er
2:1 dr
45% yield
73:27 er
2:1 dr
48% yield
81:19 er
4:1 dr
36% yield
50:50 er
2:1 dr
3.69a 3.69b 3.69c 3.69d
3.69e 3.69f
3.69g 3.69h 3.69i
3.69j 3.69k
3.69l 3.69m
(21)2.0 equiv.
2.0 equiv.
	  132	  
Figure 3.17 Catalyst screen of the multicomponent cycloaddition. 
 
Synthesis of (R)- and (S)-VAPOL 
 
 (R)- and (S)-VAPOL 3.69m were both synthesized from racemic VAPOL in high 
enantiopurity from previously established protocols (Figure 3.18, Eq. 22).147–149 Thionyl 
chloride provided the acyl chloride of 2-naphthyl acetic acid 3.73. The crude material 
was carried forward in a cascade reaction with phenyl acetylene to 3.74 in 60% yield over 
two steps. An oxidative phenol coupling of the phenol delivered racemic VAPOL (±)-
3.69m in 65% yield. (-)-Cytisine 3.75 was isolated from the seeds of Laburnum 
anagyroides cytisus and acylated to give 3.76 in 85% yield (Figure 3.18, Eq. 23). 
Hydrogenation using Adam’s catalyst followed by lithium aluminum hydride reduction 
provided (-)-O’Brien’s catalyst 3.77 in 67% yield. A copper-mediated resolution of (±)-
3.69m provided both (R)-3.69m and (S)-3.69m in high levels of enantiopurity from chiral 
diamine catalysts (-)-sparteine 3.78 and (+)-O’Brien’s catalyst 3.77. HPLC was used to 
measure the enantiomeric ratios of products (S)-3.69m and (R)-3.69m on a chiral 
stationary phase, which confirmed the effectiveness of the resolutions (Figure 3.19). 
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Figure 3.18 Syntheses of (R)- and (S)-VAPOL via chiral resolution. 
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Figure 3.19 HPLC to confirm the enantiopurity catalyst. 
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Optimizations of the Multicomponent Cycloaddition 
 
 Final optimizations of the multicomponent cycloaddition reaction were initiated 
after catalysts (R)- and (S)-3.69m were prepared in gram quantities.  The catalyst loading 
was lowered to 15 mol % with a slight loss of yield and stereoselectivity (Table 3.2, 
Entry 2). The reaction concentration was increased to see its overall effect on yield and 
stereoselectivity (Table 3.2, Entry 3). The quantity of triisopropyl borate was decreased 
to observe its effect on the enantiomeric ratio, which dropped to 79:21 er when only 0.45 
equivalents were used (Table 3.2, Entries 4-6). Wulff observed a similar effect during his 
investigation of BOROX-catalysts.150 The reaction was run with styrene 3.68 as limiting 
reagent and also in excess. Surprisingly, both yields were similar which may indicate that 
dimerization of the in situ generated ortho-quinone methide is not a preferred pathway 
under these conditions (Table 3.2, Entries 7 and 8). A large increase in yield and 
stereoselectivity was observed when the temperature was raised to 100 °C (Table 3.2, 
Entry 9). Other high boiling solvents were tested in the reaction; trifluorotoluene was 
selected as the solvent of choice providing an impressive 95% yield, 84:16 er and 7.6:1 dr 
(Table 3.2, Entries 10-13). The reaction was run at lower temperatures in an attempt to 
increase the enantioselectivity, but the yield was compromised (Table 3.2, Entries 14 and 
15).  	  
Table 3.2 Further optimizations of the multicomponent cycloaddition. 
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O
O O
OCH3
O
O OH
OCH3
OCH3
15 mol % 
(R)-3.69m
B(OiPr)3
conditions
+
OCH3
3.66 3.72
3.68
3.71
1a
Reactions were run at 80 °C with 0.4 mmol of phenol, 0.8 mmol of aldehyde dimethyl acetal, and 
0.8 mmol of styrene with 15 mol % (R)-3.69 for 24 h unless otherwise indicated. Diastereomeric 
ratios were determined by 1H NMR. Enantiomeric ratios are reported for the major diastereomer. 
[a] 0.30 equiv. of (R)-3.69 were used. [b] 2.0 equiv. 3.66, 2.0 equiv. 3.68, 1.0 equiv. 3.72 were 
used. [c] 1.0 equiv. 3.66, 1.0 equiv. 3.68, 20.0 equiv. 3.72 were used, neat. [d] 16 h reaction time. 
[e] 1.0 equiv. 3.66, 1.0 equiv. 3.68, 1.0 equiv. 3.72 were used. [f]  20 h reaction time. [g] 2.0 equiv. 
3.66, 1.0 equiv. 3.68, 1.0 equiv. 3.72 were used. [h] 1.0 equiv. 3.66, 2.0 equiv. 3.68, 1.0 equiv. 
3.72 were used. [i] 1.0 equiv. 3.66, 1.0 equiv. 3.68, 2.0 equiv. 3.72 were used.[j] recrystallization 
from hot hexanes.
2.0 0.4 5.0:1
entry B(OiPr)3equiv.
temp.
[°C] solvent
rxn
concn [M]
yield
[%] er dr
80 56 88:12PhCH3
2 2.0 0.4 4.0:180 43 86:14PhCH3
3 2.0 0.6 4.3:180 37 86:14PhCH3
4 1.0 0.4 4.3:180 51 86:14PhCH3
5 0.60 0.4 5.5:180 33 87:13PhCH3
6 0.45 0.4 4.5:180 35 79:21PhCH3
7b 0.60 0.4 5.5:180 36 76:24PhCH3
8c 0.60 0.4 2.0:180 41 80:20PhCH3
9 0.60 0.4 5.5:1100 74 84:16PhCH3
10 0.4 4.5:165 77:23
11 0.4 3.8:1100 27 74:261,4-dioxane
13 0.4 7.6:1100 95 84:16PhCF3
14 0.4 7.3:190 64 84:16
15 0.4 7.2:180 68 83:17
16d 0.4 8.1:1100 87 88:12
17e 0.4 10.9:1100 55 85:15
18d,e 0.4 11.4:1100 56 90:10
19d,e 0.6 10.1:1100 55 85:15
20e,f 0.3 11.4:1100 46 88:12
21d,g 0.4 9.0:1100 51 84:16
22d,h 0.4 9.8:1100 67 86:14
23d,i 0.4 8.0:1100 59 85:15
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
0.60
100 mesitylene
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
PhCF3
12 0.4 5.2:1100 85 77:23PhCl0.60
24d,j 0.4 >20:1100 63 95:050.60 PhCF3
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 Previous multicomponent cyclization studies indicated that prolonged reaction 
times at high temperatures erode the enantioselectivity of electron-rich 2,4-diaryl 
chroman products. Thus, the reaction was set to run for only 16 hours, which provided 
87% yield, 88:12 er, and 8.1:1 dr (Table 3.2, Entry 16). The ratio of starting material 
equivalents was varied in combination with reaction times (Table 3.2, entries 17-23). 
Ultimately, chroman product 3.71 was obtained in 65% yield, 95:5 er, and >20:1 dr after 
a recrystallization procedure was paired with optimized conditions (Table 3.2, Entry 24). 
 
Crystal Structure of Product Confirms the Absolute Stereochemistry 
 
 X-ray crystallography was used to determine the absolute stereochemistry of the 
2,4-diaryl chroman product 3.71 to be (R,S) as indicated (Figure 3.20). 
 
O
(R)
(S)O
O
OCH3(R,S)-3.71
(R,S)-3.71
	  138	  
Figure 3.20 X-ray crystallography of product confirmed absolute stereochemistry. 
 
Myristinins A-C 
 
 Ortho-quinone methides were discovered to be key intermediates in the 
biosynthesis of chroman containing natural products and have since been used effectively 
in biomimetic syntheses.72,133,151,152 The cycloaddition of ortho-quinone methides 
provides direct access to chromans, which is considered a privileged scaffold due to its 
observed frequency in biologically significant natural products and pharmaceutical 
drugs.144,153,153–155  Sawadjoon first isolated myristinins A-F from a CH2Cl2 extract of 
Myristica cinnamomea, a plant commonly found in the south of Thailand, and reported a 
chroman scaffold within its structure.122 Flavan compounds are believed to follow a 
phenylpropanoid biosynthetic pathway proceeding through ortho-quinone methide 
intermediates.156 We sought to demonstrate the high efficiency of the newly developed 
multicomponent organoboron cycloaddition and its rapid access to synthetically 
important architectures. Herein, we report the synthetic efforts to construct the core of 
myristinins A-C using the multicomponent organoboron cycloaddition reaction involving 
ortho-quinone methides. 
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Figure 3.21 Myristinin natural products exhibit atropisomerism at room 
temperature. 
 
The myristinin family of natural products was found to be the first example of 
atropisomeric flavans isolated from nature. The rotation of aryl ring C in 3.1b is hindered 
due to the steric interactions of its bis-ortho-hydroxyl groups with aryl ring A, rendering 
the compound atropisomeric at room temperature (Figure 3.21).  
Hecht first synthesized myristinins A-C in 2005 and 2006, which are the only 
total syntheses of myristinins A-C to date.124,157 These natural products were both 
synthesized in about 10% yield overall in 18 steps total, featuring a diastereoselective 
coupling reaction. They found 3.1a and 3.1b/c could be separated by preparative 
reversed-phase HPLC (Figure 3.22, Eq. 25). 
 
HO O
OH
HO O
OH
myristinin B
3.1b
A
B
D
C
2
34
2'
O
H
8
1'
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Figure 3.22 Previous syntheses of myristinins A-C. 
 
 Gharpure utilized an in situ generated ortho-quinone methide intermediate in a 
diastereoselective formal synthesis of 3.1b/c myristinins B/C (Figure 3.23, Eq. 26).158 
Benzyl alcohols were used as ortho-quinone methide intermediate precursors. Ortho-
quinone methide formation was catalyzed by 50 mol % loading of racemic BINOL-
derived phosphoric acid (±)-3.83. This method constitutes a mild protocol for the 
synthesis of 2,4-diaryl chroman products from the cycloaddition reaction of an in situ 
generated ortho-quinone methide and dienophile. Palladium-catalyzed arylations of 4H-
chromenes have also provided diastereoselective access to the core of myristinins B/C, 
but did not proceed through an ortho-quinone methide pathway.159  
HO O
OH
HO OH
OH O
10
BnO
H
O
OHBnO
O
+
18 steps; 9.8% overall
HO O
OH
HO OH
OH O
10
18 steps; 10.8% overall
4:1 mixture BC:A
3.1a
3.1b/c
3.79
3.80
(25)
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Figure 3.23 Phosphoric acid catalyzed formation of ortho-quinone methide in a 
formal synthesis of myristinins B/C. 
 
Progress Towards the Syntheses of Myristinins A-C via the Multicomponent 
Cycloaddition of Ortho-Quinone Methide Intermediates 
 
 Protected phenol 3.56, aldehyde 3.58, and styrene 3.68 were selected to assemble 
chroman product 3.86 through the multicomponent organoboron cycloaddition reaction 
(Figure 3.24, Eq. 28). Boron tribromide was considered for a global aryl methyl ether 
deprotection to provide rapid access to myristinins A-C 3.1. 
 
BnO O
OBn
H3CO OCH3
OCH3O
10
3.85
BnO O
OBn
H3CO OCH3
OCH3
I
OBnBnO OH
H3CO OCH3
OCH3
I
OH
3.81 3.82
3.84
50 mol % (±)-3.83
CH2Cl2, rt, 20 min
O
O
P
OH
O
Phosphoric acid
(±)-3.83
4.0 equiv.
steps
90% yield
9:1 dr
(26)
3.84 (27)
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Figure 3.24 Proposed route to myristinins A-C by a multicomponent cycloaddition 
involving an ortho-quinone methide intermediate. 
 
 A Friedel-Crafts acylation was used to synthesize aldehyde 3.58 in 65% yield, but 
partially deprotected the substrate during the reaction, regardless of the temperature 
implemented, providing aldehyde 3.88 (Figure 3.25, Eq. 29). Desired product 3.58 was 
not observed when lower quantities of Lewis acid were used. Lewis acid-promoted 
methyl aryl ether deprotections are known to occur ortho to carbonyl functional 
groups.160 1D NOE was used to confirm the regioselectivity of the aryl methyl ether 
deprotection. 
 
 
Figure 3.25 Synthesis of aldehyde for myristinins A-C. 
O
OH
+
OCH3 OCH3
H3CO OCH3
OCH3O
10
H3CO
H3CO OCH3
OCH3O
10
H3CO O H BBr3
3.56
3.68
3.58
3.86
3.1
MCR
cycloaddition
conditions (28)
3.59
Cl
O
10
1.1 equiv.
2.1 equiv. AlCl3 
CH2Cl2, rt, 15 min
3.87
65% yield
+
3.88
(29)H3CO OH
OCH3O
10
O H
H3CO OCH3
OCH3
O H
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 The multicomponent organoboron cycloaddition reaction was run in the presence 
of racemic diol catalysts (±)-3.69m at 1 and 16 hour reaction times to give product 3.89 
in 20% and 27% yields respectively with high diastereomeric ratios after recrystallization 
(Table 3.3, Entries 1 and 2). The present reaction conditions afforded another methyl aryl 
ether deprotection due to the mild Lewis acidic environment and high temperature 
combination.  Racemic 3,3’-Br2-BINOL (±)-3.69b was also tested and gave similar 
results (Table 3.3, Entries 3 and 4). Additional reactions run with longer reaction times, 
but yields higher than 27% were not observed.  
 
Table 3.3 Screening conditions to myristinin core.  
 
1
2
3
4
entry yield
[%]
20
27
16
18
>20:1
15 mol % (±)-3.69 
100 °C, PhCF3 
0.6 equiv. B(OiPr)3
drcatalyst
Reactions were run at 10 °C with 3.0 mmol of phenol, 0.50 
mmol of aldehyde, and 1.0 mmol of styrene and 0.6 equiv. 
of triisopropyl borate for given time in trifluorotoluene 
(0.3M). Recrystallizations were performed from hot hexanes.
(±)-3.69b
3.56
3.68
3.88
O
OCH3
H3CO OH
OH O
10
H3CO
3.89
(±)-3.69b
(±)-3.69m
(±)-3.69m
time
[h]
1
16
1
16
>20:1
>20:1
>20:1
OH +
OCH3
H3CO OH
OCH3O
10
H3CO O H
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Hecht deprotected a series of aryl methyl- and benzyl ethers on the myristinin 
scaffold using boron tribromide in his synthesis of myristinins B/C. Experiments were 
initiated to deprotect product 3.89 under similar conditions (Figure 3.26, Eq. 30). Boron 
tribromide was found to be harsh in the reaction mixture, which provided a mixture of 
decomposition and partially deprotected substrates. Side product 3.90 was isolated from 
the reaction in 12% yield (Figure 3.26, Eq. 31). Cold methanol has found use as a mild 
quenching agent in methyl aryl ether deprotections. Unfortunately, quenching with pre-
cooled methanol afforded decomposition and methanol containing side products, which 
may indicate oxidation of the scaffold during the deprotection (Figure 3.26, Eq. 32). 
Boron trichloride in combination with tetra-n-butylammonium iodide is reported as a 
mild method to deprotect aryl methyl ethers, but in this case furnished deprotected side 
product 3.92 and oxidized product 3.93 (Figure 3.26, Eq. 33).161 
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Figure 3.26 Studies of the aryl methyl ether deprotection. 
 
O
OCH3
H3CO OH
OH O
10
H3CO
3.89
1. 15 equiv. BBr3, 
CH2Cl2 (0.01M) 
-78 °C → -20 °C 12 h
decomposition
2. H2O quench
1. 30 equiv. BBr3
CH2Cl2 (0.01M)
-78 °C → rt 4 h
decomposition
2. cold MeOH 
quench
1. 15 equiv. AlBr3
EtSH, 0 °C → rt 20 h
decomposition
2. CHCl3 dilution
0 °C MeOH quench
3.89+
OH
H3CO OH
OH O
10
H3CO
12% yield
+
1. 30 equiv. BCl3 
15 equiv. NBu4I
CH2Cl2 (0.02M) 
-78 °C → rt
2. ice quench OH3CO O
OH O
10
OH
HO OH
OH O
10
HO
3.90
3.92
3.93
+
(31)
(33)
(34)
reaction 
conditions
O
OH
HO OH
OH O
10
HO
3.1
(30)
3.89
3.89
3.89
3.89
(32)
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 A weaker Lewis acid with stronger nucleophile strategy led to decomposition and 
the recovery of starting material.162 Other variations of the mentioned conditions were 
attempted on substrate 3.89 and also met failure.  
 
 
Figure 3.27 Synthesis of benzyl protected starting materials. 
 
Benzyl protecting groups were selected as a means to protect the myristinin core 
due to their more labile nature. Resorcinol 3.94 was protected using benzyl bromide 3.95 
and potassium carbonate in refluxing acetone to furnish benzyloxyphenol 3.96 in 36% 
yield (Figure 3.27, Eq. 35). Wittig olefination using freshly prepared phosphonium salt 
provided benzyloxystyrene 3.82 in 85% yield from the commercially available aldehyde 
starting material 3.97 (Figure 3.27, Eq. 36). 
 
HO OH
O OH
Br+
1.2 equiv.
1.0 equiv. K2CO3
acetone, reflux, 4 h
36% yield
O
H
O nBuLi, Ph3PCH3I
0 °C, 15 min
3.94 3.95 3.96
3.97
O
3.82
85% yield
(36)
(35)
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Figure 3.28 Optimizations of multicomponent cycloaddition using benzyl protected 
starting materials. 
 
 The multicomponent organoboron cycloaddition reaction was run under the 
previously optimized conditions utilizing VAPOL catalyst (±)-3.69m, but provided 
OH
+
OBn
H3CO OH
OCH3O
10
BnO
O H
3.88 O
OBn
H3CO OH
OH O
10
BnO
0.6 equiv. B(OiPr)3
15 mol% (±)-3.69m 
PhCF3 (0.3M)
100 °C, 16 h
3.96
3.82
<10% yield
aldehyde consumed
2.2 equiv. B(OiPr)3 
CF3Ph (1.0M)
100 °C, 8 h
5.0 equiv. 27% yield
>20:1 dr
2.0 equiv.
2.2 equiv. B(OiPr)3
15 equiv. CF3CH2OH
2.2 equiv. 3.99
80 °C, 2 h
3.0 equiv. 34% yield
>20:1 dr
1.2 equiv.
2.2 equiv. B(OiPr)3
15 equiv. CF3CH2OH
2.2 equiv. 3.99
80°C, 12 h
5.0 equiv. 63% yield
>20:1 dr
1.2 equiv.
(37)
(39)
(40)
(41)
3.98
5.0 equiv. 2.0 equiv.
reaction 
conditions
(38)
3.96 3.88 3.82+ +
3.96 3.88 3.82+ +
3.96 3.88 3.82+ +
3.96 3.88 3.82+ +
HO
butylated
hydroxytoluene
3.99
3.98
3.98
3.98
3.98
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product in less than 10% yield (Figure 3.28, Eq. 38). We considered that the borate is 
rendered inactive after deprotecting the methyl aryl ether group under these conditions. 
As such, we increased the equivalents of borate used to accommodate this observation. 
VAPOL catalyst (±)-3.69m was removed from the reaction mixture to prevent any 
potential Friedel-Crafts condensation pathways from occurring. Moreover, styrene 3.82 
was added in excess to outcompete any ortho-quinone methide intermediate 
homodimerization. Under these collective conditions, product 3.98 was obtained in 27% 
yield with high diastereoselectivity. Tris(2,2,2-trifluoroethyl)borate was reported to have 
higher relative Lewis acidity due to the electron-withdrawing induction from the 
trifluoroethanol alkyoxy groups attached.163 Additionally, DFT calculations have 
indicated that highly polar solvents lower the activation energy of cycloadditions with 
ortho-quinone methides.164 We postulated that the reaction could benefit from a stronger 
Lewis acid, since the sterically demanding and electron-rich aldehyde 3.88 has proven to 
give lower rates of product formation. Trifluoroethanol was added to the reaction mixture 
with the intent to generate a more active Lewis acid in situ. We also postulated that the 
methyl aryl deprotection would benefit from a proton source to furnish the product and a 
nucleophile to recycle the Lewis acid.165 Butylated hydroxytoluene is known for its 
suppression of single electron oxidation, which was postulated as a potential pathway 
leading to the formation of undesired side products.166 The addition of trifluoroethanol in 
combination with butylated hydroxytoluene 3.99 provided product 3.98 in 34% yield 
after only 2 hours (Figure 3.28, Eq. 40). Allowing the reaction to run for 12 hours 
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furnished product 3.98 in 63% yield with high levels of diastereoselectivity (Figure 3.28, 
Eq. 41). 
 
 
Figure 3.29 Deprotection of polyphenol natural product must be fully protected 
before successful deprotection. 
 
Product 3.98 was subjected to the exact aryl methyl ether deprotection conditions 
used by the Hecht group; unfortunately, like tetramethyl-protected product 3.89, 
decomposition was observed. Similar observations were made in the literature reported 
by the Snyder group during the total synthesis of vaticanol A 3.102 (Figure 3.29, Eq. 
42).167 Benzylic oxidation of 3.100 by DDQ generated an ortho-quinone methide 
vaticanol A
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OCH3
OCH3
OCH3
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OCH3
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HO HH
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BBr3X
3.103
500 equiv. MeI
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95% yield88% yield
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intermediate, which was quickly trapped by a neighboring phenol to provide 3.101 in 
40% yield. Global deprotection of 3.101 failed under a number of conditions assessed, 
which gave partially demethylated materials. Snyder postulated that the order of 
deprotection is critical for highly polar compounds to maintain solubility; others have 
reported similar observations as well. Thus, product 3.101 was fully methylated to 3.103 
before global deprotection with BBr3 provided vaticanol A 3.102 in a 95% yield (Figure 
3.29, Eq. 43). Experiments were initiated to methylate product 3.98 given the information 
reported by Snyder in the literature and are currently underway.167 
 
Proposed Mechanism and Model of Selectivity  
 
  A correlation between yield and the solvent dielectric constant ε, a measurement 
of polarity, was found while screening reaction conditions. Low polarity solvent 
mesitylene (ε = 2.27 at 25 °C) gave just a 65% yield and 4.5:1 dr, whereas higher polarity 
solvent chlorobenzene (ε = 6.08 at 25 °C) provided product in 85% yield and 5.2:1 dr 
(Table 3.5, Entries 2 and 4). A DFT study investigating Diels-Alder reactions of ortho-
quinone methides with various substituted ethenes found that the activation energy 
decreases as the dielectric constant of various solvents increases.164 They explained that 
the lowering of the activation energy is a result of the larger solvation of the ortho-
quinone methide zwitterionic transition state; though, the proposed mechanism was found 
to be an asynchronous concerted cycloaddition. 
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Table 3.5 Relationship between solvent polarity and yield in asymmetric MCR. 
 
 
A mechanistic model is proposed that accounts for the experimental observations.  
The reaction sequence is initiated by the formation of a VAPOL-borate complex 3.104 
through the single exchange of an isopropoxy-ligand (Figure 3.30, Eq. 44). A boron 
mediated Friedel-Crafts hydroxy-alkylation condensation affording a dioxaborin 
intermediate 3.105 is proposed.168,169 Other VAPOL-borate complexes such as BOROX 
are known to occur with VAPOL, but require water and imine base to assemble 
spontaneously in solution.170 Intermediate 3.105 is postulated to be in equilibrium with a 
stabilized ortho-quinone methide intermediate 3.106, which undergoes an asynchronous 
concerted cycloaddition with styrene 3.68 to afford product. Consistent with the 
aforementioned DFT study164 and experimental observations of cycloadditions with 
O
O O
OCH3
O
O OH
OCH3
OCH3 15 mol % (R)-3.69m
0.60 equiv. B(OiPr)3
100 °C, solvent, 24 h+
OCH3
3.66 3.72
3.68 3.71
entry solvent yield[%] erdr
3 5.5:174 84:16PhCH3
2 4.5:165 77:23
1 3.8:127 74:261,4-dioxane
5 7.6:195 84:16PhCF3
mesitylene
4 5.2:185 77:23PhCl
dielectric 
constant 
[ε]
2.38
2.20
9.18
2.27
6.08
dielectric constants referenced were reported at 25 °C.
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ortho-quinone methides,27,40 approach of the dienophile is endo-selective and provides a 
syn-chroman product. 
 
 
Figure 3.30 Proposed mechanism of asymmetric multicomponent cycloaddition. 
 
 A transition state model is proposed that explains the stereochemical outcome of 
the reaction. (R)-VAPOL (R)-3.69m is bound to boron and facilitates the extrusion of 
methanol to form ortho-quinone methide with the preferred (E)-olefin geometry (Figure 
3.31). The extended π-system of the phenanthrenol portion of the catalyst stabilizes the 
reactive intermediate with π-π interactions, which explains its enhanced performance 
compared to the BINOL scaffolds in our experimental observations. Approach of the 
dienophile is endo selective, which is consistent with known ortho-quinone methide 
cycloaddition chemistry. The borate-VAPOL complex hinders approach from the top 
face (Re face) in the transition state and approach of the dienophile is facially selective 
(44)
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for the Si face of ortho-quinone methide, which provides the experimentally observed 
stereochemical outcome. 
 
 
 
 
Figure 3.31 Borate-VAPOL complex provides facial selectivity in enantio-
determining transition state. 
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Conclusion 
 
The enantioselective multicomponent condensation reaction of phenols, aldehydes 
and electron rich boronates was demonstrated to form chroman structures via cyclization 
at high temperature. The myristinin family of natural products contains a privileged 
chroman scaffold within its core, which was targeted utilizing the multicomponent 
cyclization strategy. The initial boronate addition to the ortho-quinone methide was 
demonstrated, however, the high reaction temperatures in combination with the electron-
rich substrate lead to polymerization products.  
In the presence of a dienophile, ortho-quinone methides can participate as hetero-
diene partners in inverse electron demand cycloaddition reactions at low temperature. A 
boron-mediated multicomponent reaction was developed using phenol, aldehyde, and 
styrene to circumvent the reactivity issues observed in the cyclization. The core of 
myristinins B/C was synthesized utilizing this alternative strategy with impressive step 
economy, in 63% yield and >20:1 diastereoselectivity. Deprotection of the peripheral 
protecting groups was met with failure due to decomposition and oxidation products, 
which have been observed previously in polyphenol literature.  
An asymmetric variant of the multicomponent reaction was developed founded 
upon similar principles in the boronate exchange methodology previously reported by our 
group. Borate Lewis acid and chiral biphenol were implemented as a catalyst system to 
fulfill two indispensible roles in transformation; it mediated the Friedel-Crafts hydroxy-
alkylation reaction while simultaneously provided facial selectivity in the cycloaddition 
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event. Catalyst optimizations revealed (R)-VAPOL as the optimal chiral diol and 
triisopropyl borate as the effective Lewis acid, which afforded 2,4-diaryl chroman 
product in 95:5 er and >20:1 dr. This enantioselective multicomponent approach is a 
highly convergent and practical way to access ortho-quinone methides in situ for use in 
cycloaddition reactions. 	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Experimental Section 
General Information  	  
All 1H NMR, and 13C NMR spectra were recorded using a Varian 500 MHz VNMR 
spectrometer at ambient temperature in CDCl3. Chemical shifts are reported in parts per 
million as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broad), coupling constant, and integration. Infrared spectra 
were recorded on a Nicolet FT-IR with ATR. Optical rotations were recorded on a 
Rudolph Autopol II polarimeter at 25°C, and were reported as [α]D (conventional).  
Optical rotations for chroman substrates were reported as diastereomeric mixtures. 
Analytical thin layer chromatography was performed using Sorbent Technologies silica 
gel HL TLC plates (UV 254 nm, 250 µm) or neutral alumina TLC plates (UV 254 nm, 
250 µm). Flash column chromatography was performed on ZEOprep 60 ECO 40-63 
academic grade silica gel from Sorbent Technologies. Aluminum oxide type CG-20 and 
aluminum oxide activated, neutral, Brockmann I from Sigma-Aldrich were also used. 
Chiral HPLC analysis was performed using an Agilent 1100 series HPLC with a diode 
array detector. Chiral columns include Chiralcel®OD (Chiral Technologies Inc., 
24cm×4.6mm I.D.) and Chiralpak®AD-H (Chiral Technologies Inc., 25cm × 4.6 mm 
I.D.) and Chiralpak®IA (Daicel Chemical Industries, LTD., 25cm × 4.6 mm). All 
reactions were performed under argon, in oven-dried glassware with magnetic stirring. 
(R)-BINOL and (S)-BINOL were purchased from STREM and used without further 
purification. (R)-VAPOL and (S)-VAPOL was synthesized according to known literature 
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procedures. All BINOL derivatives were prepared according to known literature 
procedures.1 All starting materials were purchased from Aldrich and used as is unless 
otherwise noted. 
 
General Procedures 
 
Procedure for (R,S)-2,4-diarylchroman (3.71): To a flame dried reaction tube containing a 
stir bar was added sesamol (0.4 mmol, 1.0 equiv.) and (R)-VAPOL (0.15 equiv.). To the 
mixture was added benzaldehyde dimethyl acetate (2.0 equiv.) and 4-methoxy styrene 
(2.0 equiv.) via µsyringe followed by 0.93 mL of trifluorotoluene. The reaction was fixed 
with a rubber septum and purged with argon for approximately 5 minutes. Triisopropyl 
borate (0.60 equiv.) was added under argon and the reaction vessel was quickly sealed. 
The reaction mixture was subjected to an oil bath at 100 °C for 16 hours. The reaction 
mixture was reduced to an oily residue by rotatory evaporation and loaded directly onto 
alumina for column chromatography on a gradient from 0-10% ethyl acetates in hexanes 
to afford product in 82% yield, 87:13 er, and 6.5:1 dr. Recrystallization was done by 
dissolving product in a minimal amount of hot reagent grade hexanes. The solution was 
allowed to crystallize at room temperature and then further cooled in an ice bath. The 
OH
O
O
OMe
OMe +
O
O
O
(S)
+
0.6 equiv. B(OiPr)3
0.15 equiv. (S)-VAPOL
100 °C, PhCF3, 16 h
O
(R)
O3.71
63% yield
95:5 er
23:1 dr
3.66 3.72 3.68
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filtrate was removed by syringe and the remaining solid provided product in 80% 
recovery (63% overall yield), 95:5 er, and 23.1:1 dr. 
 
 
Preparation of phenanthrenol (3.74): 1. To a flame dried single neck 250 mL round 
bottom flask charged with argon and equipped with a large magnetic stir bar was added 
2-naphthylacetic acid (1.0 equiv. 13.0 g, 69.8 mmol) and thionyl chloride (4.0 equiv.). A 
condenser was placed on top and was connected to a needle and tubing which led into an 
open flask containing aqueous sodium hydroxide to neutralize hydrogen chloride 
evolution, as well as sulfur dioxide.  The mixture was heated at 90°!C for one hour and 
the volatiles were removed under high vacuum. 2. The crude material in a flask fitted 
with a reflux condenser and flushed with argon was charged with phenyl acetylene (1.2 
equiv.) and isobutyric acid anhydride (2.0 equiv.). The joint was sealed well with Teflon 
tape and heated with stirring to 190 °C for 24 hours under argon. Afterwards, the reaction 
mixture was cooled to ambient temperature and aq. KOH (25g in 100 mL H2O) was 
added slowly. The biphasic mixture was stirred at 100 °C in an oil bath for an additional 
15 hours, at which time, the reaction mixture was cooled to ambient temperature. An 
extraction was done using diethyl ether. Purification on silica chromatography afforded 
OH
O
1. SOCl2, 90 °C, 1h
2. phenyl acetylene 
160 °C, 18 h
OHPh
two steps
60%
3.743.73
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product in approximately 60% yield over two steps. Spectral data was in agreement with 
reported literature values.171 
 
 
Preparation of racemic VAPOL (3.69m): A 250 mL three necked flame dried round 
bottom flask equipped with a large stir bar was charged with phenanthrol 3.74 (1.0 
equiv., 11.0 grams) and approximately 50 mL of light mineral oil under argon. A glass 
pipet was driven into a rubber septum affixed to round bottom flask and a rubber line to 
provide a steady stream of air to the reaction mixture, approximately 2-3 cm above the 
surface. The reaction was subjected to an oil bath at 170 °C for 36 hours. The reaction 
was cooled to room temperature and diluted with ethyl acetate in hexanes. A work up 
afforded a crude material, which was dry loaded onto silica for column chromatography. 
A gradient of 0-15% ethyl acetate in hexanes afforded 3.4 grams of product in a 65% 
yield. 
 
OHPh
OHPh
Ph OH
170°C light 
mineral oil, 36 h
65%
3.74
(±)-VAPOL 3.69m
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Preparation of (R)-VAPOL ((R)-3.69m): The desymmetrization of VAPOL 3.69 was 
accomplished by preparing two solutions: the copper solution, and the VAPOL solution. 
Cu(II) solution: To a 500 mL round bottom flask was added 140 mL of methanol 
(0.05M), CuCl (1.7 equiv., 7.2 mmol), and O’Briens diamine (+)-3.77 (3.4 equiv., 15.43 
mmol).  This mixture was sonicated and sparged with house air, and maintained at room 
temperature for 30 minutes. A septum was attached and the solution was purged with 
argon for 30 minutes. VAPOL solution preparation: A solution of racemic VAPOL 3.69 
(2.15 g was prepared in anhydrous dichloromethane in a large round bottom flask.  This 
was sparged with argon for 30 minutes with stirring. Cu(II)-sparteine solution was 
transferred via cannula to VAPOL solution and was sonicated for 10 minutes.  
Afterwards, the flask was covered with aluminum foil to block light and was allowed to 
stir at room temperature for 5 hours.  Saturated sodium bicarbonate was used to quench 
the reaction. A work up was done with dichloromethane and excess water (200 mL). 
Column chromatography on silica using a gradient 0-15% ethyl acetate in hexanes 
afforded 1.2 grams of (R)-3.69. HPLC Analysis: Chiralpak IA column, 24cm×4.6 mm 
I.D., Hexanes:IPA = 90:10, 1.0mL/min. tr major: 47.0 min., tr minor: 7.7 min. 
 
OHPh
Ph OH
(±)-VAPOL 3.69m
OHPh
Ph OH
56% yield, 99:1 er
(R)-3.69m
CuCl (+)-3.77 
MeOH/CH2Cl2
3 h, rt
N
NMe H
(+)-O'Brien's 
catalyst 3.77
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Preparation of (R)-VAPOL ((R)-3.69m): The procedure for the preparation for (S)-3.69m 
can be followed exactly by substitution of (+)-O’Briens diamine for (-)-sparteine (-)-3.78. 
 
 
Procedure for 4-benzyloxystyrene (3.82): Preparation of Wittig salt: Methyl iodide (1.2 
equiv.) was added slowly to a solution of triphenyl phosphine (1.0 equiv., 6.0 grams) in 
20 mL of anhydrous toluene. After the addition, the reaction mixture was warmed to 
reflux until a thick, milky solution formed, at which time it was cooled to room 
temperature. Vacuum filtration furnished approximately 9.0 grams of material that was 
dried under reduced pressure. Procedure for Wittig reaction: The Wittig salt (1.2 equiv.) 
was suspended in 50 mL of anhydrous THF in a 250 mL round bottom at 0 °C. To this 
reaction vessel was added 18.9 mL of nbutyl lithium (1.2 equiv.) as a 1.6M solution in 
hexanes over 10 minutes. 4-Benzyloxybenzaldehyde (25.2 mmol, 1.0 equiv.) was then 
added as a saturated solution in THF, slowly. The reaction mixture was allowed to warm 
to room temperature and TLC was used to monitor the reaction. After 15 minutes the 
OHPh
Ph OH
(±)-VAPOL 3.69m
CuCl (+)-3.78 
MeOH/CH2Cl2
3 h, rt
N
NH
(-)-sparteine 3.78
50% yield, 99:1 er
(S)-3.69m
OHPh
Ph OH
O
H
O nBuLi, Ph3PCH3I
0 °C, 15 min
3.97
O
3.82
85% yield
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reaction was quenched with water and concentrated to a residue. The residue was 
partially dissolved in diethyl ether and placed in a -20 °C freezer to crash out 
triphenylphosphine oxide byproduct. The organic layer was then concentrated and 
purified by column chromatography on silica using an isocratic eluent at 10% ethyl 
acetate in hexanes. 
 
 
Procedure for 3-dodecanoyl-2-hydroxy-4,6-dimethoxybenzaldehyde (3.88): To a flame 
dried round bottom containing a stir bar was added 25 mL of anhydrous dichloromethane, 
which was cooled to 0 °C. Aluminum trichloride (3.01 g, 2.2 equiv.) were added 
followed immediately by lauroyl chloride (2.88 mL, 1.2 equiv.).  The reaction mixture 
was allowed to warm to room temperature and was monitored by TLC. After 
approximately 15 minutes, the reaction mixture was poured into a separation funnel 
containing water.  The organic layer was separated and the aqueous layer was extracted 
with three portions of ethyl acetate.  The organic fractions were combined, dried with 
saturated brine solution, then with sodium sulfate for 10 minutes, and concentrated down 
to a yellow liquid, which eventually turns to a solid at room temperature. The solid was 
dissolved in dichloromethane and silica, concentrated to a powder under reduced 
3.59
Cl
O
10
1.1 equiv.
2.1 equiv. AlCl3 
CH2Cl2, rt, 15 min
3.87
65% yield
+
3.88
H3CO OH
OCH3O
10
O H
H3CO OCH3
OCH3
O H
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pressure, and loaded onto silica for column chromatography purification. An isocratic 
mixture of 15% ethyl acetate in hexanes provided product in 65% yield. Yield: 65%. 1H 
NMR (500 MHz, CDCl3): δ 12.99 (br, 1H), 10.17 (s, 1H), 5.93 (s, 1H), 3.93 (s, 3H), 3.90 
(s, 3H), 2.80 (t, J = 7.5 Hz, 2H), 1.65 (p, J = 7.5, 7.5 Hz, 2H), 1.39-1.21 (overlap, 16H), 
0.87 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 203.46, 191.29, 165.23, 165.07, 
105.92, 85.82, 77.25, 77.20, 77.00, 76.74, 55.99, 55.94, 44.80, 31.90, 29.61, 29.50, 29.45, 
29.32, 29.22, 23.98, 22.67, 14.10. 
 
 
 
Procedure for the multicomponent organoboron cycloaddition reaction (3.89): To an oven 
dried reaction tube containing a small stir bar was added phenol (0.4 mmol, 1.0 equiv.), 
aldehyde (1.2 equiv.), styrene (5.0 equiv.), and trifluoroethanol (15.0 equiv.) via µ-
syringe. The mixture was purged with argon under a rubber septum for 10 minutes and 
triisopropyl borate (2.2 equiv.) was subsequently added. The reaction tube was sealed 
under an argon environment and subjected to an 80 °C oil bath for 12 hours. The reaction 
was concentrated to a residue under reduced pressure and then loaded directly onto silica 
for column chromatography purification. Typical separation was done on a gradient from 
27% yield
>20:1 dr
15 mol % (±)-3.69m 
100 °C, PhCF3 
0.6 equiv. B(OiPr)3 16 h
3.56
3.68
3.88
O
OCH3
H3CO OH
OH O
10
H3CO
3.89
OH +
OCH3
H3CO OH
OCH3O
10
H3CO O H
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0-20% ethyl acetate in hexanes. In some cases, phenol overlapped with product during 
purification. Phenol can often be removed via recrystallization or a second purification 
with neutral alumina. 
 
 
 
Procedure for 3-benzyloxyphenol (3.96): To a flame dried round bottom flask containing 
a stir bar was prepared a solution of potassium carbonate (1.26 g, 9.09 mmol, 1.0 equiv.) 
and resorcinol (1.2 equiv.) in 10 mL of anhydrous acetone. To the mixture was added 
benzyl bromide (1.0 equiv.) via syringe. The reaction vessel was purged with argon for 
10 minutes and then a reflux condensation was attached. The reaction was placed under 
reflux at 65 °C in an oil bath for 3 hours, at which time TLC indicated the consumption 
of starting material. The reaction mixture was cooled to room temperature and then 
poured into a separatory funnel containing a portion of water. This mixture was extracted 
with ethyl acetate three times. The organic fractions were combined, washed with 
saturated brine solution, and then dried over sodium sulfate. Column chromatography on 
a gradient from 15-30% ethyl acetate in hexanes on silica afforded product in 35% yield. 
Spectral data are in agreement with reports in literature. 
 
HO OH
O OH
Br+
1.2 equiv.
1.0 equiv. K2CO3
acetone, reflux, 4 h
36% yield
3.94 3.95 3.96
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Procedure for benzyl protected chroman (3.98): To a flame dried reaction tube was added 
3-benzyloxyphenol (0.5 mmol, 1.0 equiv.), aldehyde (1.2 equiv.), butylated 
hydroxytoluene (2.2 equiv.), and styrene (5.0 equiv.). Trifluoroethanol (15.0 equiv.) was 
added by syringe and to the vessel was added a rubber septum. The reaction mixture was 
purged with argon for 5 minutes, borate was added under argon via syringe, and then the 
vessel was quickly sealed and transferred to an oil bath preset to 80 °C for 12 h. The 
reaction mixture was added directly to silica for column chromatography eluted with a 
gradient of 0-15% ethyl acetate in hexanes. 
 
Characterization Data 
 
(R,E)-5-methoxy-2-(3-(4-methoxyphenyl)-1-(2,4,6-trimethoxyphenyl)allyl)phenol(3.61): 
The general procedure for the asymmetric multicomponent addition of boronates to in 
situ generated ortho-quinone methides from chapter 1, experimental section, general 
procedures.  The crude mixture was purified by flash column chromatography with 
elution from 0-20% ethyl acetate in hexanes. Yield: 30% Enantiomeric Ratio: 87:13 
OH
+
OBn
H3CO OH
OCH3O
10
BnO
O H
3.88 O
OBn
H3CO OH
OH O
10
BnO
3.96
3.82
3.98
2.2 equiv. B(OiPr)3
15 equiv. CF3CH2OH
2.2 equiv. 3.99
80°C, 12 h
63% yield
>20:1 dr
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HPLC Analysis: Chiralcel OD column, 24cm×4.6 mm I.D., Hexanes:IPA = 95:05, 
1.0mL/min. tr major: 8.4 min., tr minor: 9.2 min. 1H NMR (500 MHz, CDCl3): δ 7.33-
7.25 (m, 3H), 6.88-6.81 (m, 2H), 6.80 (d, J = 15.0 Hz, 1H), 6.39-6.46 (m, 2H), 6.35 (d, J= 
15.0 Hz, 1H), 6.18 (dtd, J = 15.1, 6.9, 1.4 Hz, 1H), 5.33 (br, 1H), 3.84 (s, 3H), 3.80 (s, 
3H), 4.75 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 160.09, 159.21, 157.99, 155.22, 
130.96, 130.65, 130.31, 129.36, 129.18, 128.75, 127.58, 126.95, 121.06, 114.46, 113.84, 
113.24, 111.43, 109.99, 105.84, 105.54, 101.63, 101.35, 91.82, 56.00, 55.38, 55.23, 
37.78. MS (m/z): calculated for [C26H28O6H+]: 437.2 m/z; found 437.2 m/z. 
 
1-(2,6-dihydroxy-4-methoxy-3-(7-methoxy-2-(4-methoxyphenyl)chroman-4-
yl)phenyl)dodecan-1-one(3.89): 1H NMR (500 MHz, CDCl3): δ13.92 (s, 1H), 10.23 (s, 1 
h) 7.33 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 9.1 Hz, 1H), 6.91 (d, J = 8.5 Hz, 2H), 6.68-6.63 
(overlap, 2H), 6.29 (s, 1H), 5.28 (d, J = 10.8 Hz, 1H), 4.10 (dd, 10.8, 4.4 Hz, 1H), 3.82 (s, 
3H), 3.81 (s, 3H), 3.3.71 (s, 3H), 2.80-2.65 (overlap, 3H), 2.0 (q, J = 12.2 Hz, 1H), 1.59 
(p, J = 14.6, 7.5 Hz, 2H), 1.39-1.10 (overlap, 15H), 0.87 (t, J = 7.1 Hz). 13C NMR (126 
MHz, CDCl3): δ 204.50, 159.42, 156.55, 153.29, 153.13, 151.59, 132.99, 127.18, 125.84, 
115.69, 114.70, 113.89, 109.82, 102.01, 100.96, 92.25, 78.28, 55.90, 55.47, 55.29, 44.98, 
34.62, 31.92, 29.65, 29.64, 29.53, 29.46, 29.35, 29.19, 28.67, 23.92, 22.69, 14.12. 
 
1-(3-(7-(benzyloxy)-2-(4-(benzyloxy)phenyl)chroman-4-yl)-2,6-dihydroxy-4-
methoxyphenyl)dodecan-1-one(3.98): 1H NMR (500 MHz, CDCl3): δ13.93 (s, 1H), 9.89 
(s, 1H), 9.97.48-7.29 (m, 12H), 7.12 (d, J = 9.2 Hz, 1H), 6.99 (d, J = 8.7 Hz, 2H), 6.77-
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6.70 (overlap, 2H), 6.30 (s, 1H), 5.27 (d, J = 10.8 Hz, 1H), 5.08 (s, 2H), 5.06 (s, 2H), 4.09 
(dd, J = 10.8, 4.6 Hz, 1H), 3.79 (s, 3H), 2.80 (overlap, 3H), 2.01 (q, J = 12.0 Hz, 1H), 
1.60 (m, 2H, 1.39-1.15 (overlap, 16H), 0.86 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, 
CDCl3): δ 204.38, 158.67, 158.60, 156.58, 153.29, 153.13, 151.58, 136.90, 136.70, 
133.28, 128.60, 128.57, 128.02, 127.97, 127.43, 127.41, 127.19, 125.87, 116.03, 114.87, 
114.86, 114.78, 110.69, 103.09, 100.96, 92.32, 78.26, 70.22, 70.07, 55.90, 44.99, 34.60, 
31.91, 29.69, 29.66, 29.64, 29.53, 29.45, 29.35, 29.20, 28.71, 23.92, 22.67, 14.10. 
 
1D NOE of cis-3.89 	  
 
A 1D NOE of the 2,4-diaryl chroman product 3.89 reveals the relative stereochemistry as 
cis. Proton Hb was irradiated and a 5% NOE was observed in proton Ha.  
O
O
O OH
OH O
O
Ha
Hb
Hb
Ha
cis-3.89
1H NMR
1D NOE
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X-Ray Crystallography Data 
 
Crystal data and structure refinement for (R,S)-3.71: 	  	    Empirical formula  C23 H 20 O4 
 
Identification code  CCDC barbato1 
Space group  P21 
Unit cell lengths a 10.4433(5)  
b 10.1353(4) 
c 34.1876(16) 
Cell angles a 90° 
b 98.665(3) 
g 90° 
 
Cell volume 3577.32 
Z, Z’ Z = 8, Z’ = 0 
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